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A B S T R A C T 
We have investigated the loss of heterozygosity (LOH) pattem of 
chromosome 11 on fifty-one primary nasopharyngeal carcinomas (NPC) using 12 
microsatellite polymorphic markers. The results revealed that 29 out of the 51 cases 
(56.7%) demonstrated LOH on at least one of the nine 1 lq microsatellite loci studied. 
Multiplex PCR analysis confirmed that allelic imbalances in loci JNT-2 and 
D11S873 were amplified in three of the cases. The highest frequencies of LOH were 
found at the two loci D11S2000 (38.2%) and D11S934 (39.3%), both located at 
1 lq22-24. Two distinct regions of deletion were found at chromosome 1 lq. The first 
deletion region was defined by JNT-2 and D11S900 at llql3.3-22, and the second 
one was located between D11S2000 and D11S528 at 1 lq22-23.3. The two deletion 
regions overlap with the common areas of deletion reported in other tumor types. 
This suggests the presence of multiple putative tumor suppresser genes on 
chromosome 1 lq that may play a role in the development ofNPC. 
Cell-666 is one of the rare existing EBV-positive long term cultured NPC 
cells established in our laboratory. The NPC cells have been serially passage 45 times 
at the time of preparing this thesis. Aberrant methylation of 5'CpG island of pl6 
gene, a negative cell cycle regulator, was previously detected in these cells by a 
colleague of mine. Cell-666 represents a valuable modal for the study of NPC 
tumorigenecity. The karyotype of these newly established cells has been examined, 
and described as followings: 
45,Xdel(X)(q24),der(5)(5pter^5q3 l::5ql3^5q3 l::5pl2^5pter),-5, 
der(?;6)(plO;qlO),add(7)(p22),+9,del(ll)(ql3),add(iqOpl3),-14,-18,-21,+2mar 
Consistent presence of two marker chromosomes has been identified. Fluorescence 
in-situ hybridization (FISH) analyses have been performed using total chromosome 
painting probes of chromosomes 5, 6, 11, 12, 14 and 18. This confirmed some ofthe 
suspected chromosomal abnormalities such as del(ll)(ql3) identified using 
molecular genetic approach. FISH analysis also revealed several chromosomal 
rearrangements that had not been found in the karyotype analysis. 
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CHAPTER 1 
LITERATURE R E ^ f f i W 
I. Nasopharyngeal carcinoma 
Nasopharyngeal carcinoma Q^?C) is one of the common cancers among the 
Chinese populations from areas of south-east Asia and southern China. Central 
Guangdong Province and eastem Guangxi Province are the regions with highest 
incidences (Yu et al, 1988). The age-specific incidence rates of both sexes are found to 
begin to rise at an early age of 20，with the plateau at the age between 35-64, then start to 
decline thereafter (Muir et al, 1987). Males are reported to have much higher incidence 
rate ofNPC with the ratio of men to women is around 2-3 to 1 (Hildesheim and Levine, 
1993). This phenomenon is different in the Caucasian populations who have only very 
low incidence rate of less then 1 per 100,000 (Hildesheim and Levine, 1993). Hong 
Kong is also one of the high incidence countries with which more than 90% of its 
population are from the Guangdong origin. As shown in the Annual Report of the 
Department of Health, NPC (772 cases) is the third common cancer type in men in the 
new cancer cases notified in 1991. This report also showed that 398 people died ofNPC 
in 1994, with which 303 are men and 95 are women. 
The nasopharynx refers to areas at the back of the nasal cavity which is located at 
the base of the skull and the end of aerodigestive tract. This tubular space belongs to 
part of the pharynx which can communicate with the nasal cavities and the middle ear 
(Yew, 1991). The epithelial lining of the nasopharynx consists of stratified squamous 
cells, pseudostratified columnar ciliated cells, and some patches of cells of an 
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intermediate type (Shanmugaratnam, 1982). NPC is an epithelial malignancy of the 
nasopharynx surface epithelium. It raised from any of the three previous mentioned 
epithelial cells (Shanmugaratnam, 1982). The fossa of Rosenmuller represents the 
commonest site of origin ofNPC and is therefore of great clinical importance. According 
to the World Health Organization classification system, NPC can be divided into three 
types based on the degree of differentiation (WHO, 1978). 
1. Type I: squamous cell carcinoma 
Carcinomas ofthis type can be further divided into three grades, including: 
1. well differentiated, 2. moderately differentiated, 3. poorly differentiated. 
2. Type II: nonkeratinizing carcinoma 
3. Type III: undifferentiated carcinoma 
The majority of NPC cases in the low-risk group (Caucasian populations) 
belongs to WHO type I classification of squamous cell carcinomas. On the other hand, 
NPC cases among Southern Asian are mostly the undifferentiated carcinoma of WHO 
type III classification. 
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II. Etiology ofNPC 
The etiology of this geographically and ethnically specific malignancy has been 
reported to be related to multi-factors (Ho, 1971). Many different factors may contribute 
to the development of this cancer. Some studies reported that exposure to widespread 
environmental factors at early age, or combination of environmental and genetic factors 
can be associated with the etiology of NPC (Geser et al, 1978，Huang, 1992). 
Epidemiological studies generally believed that NPC was associated with the following 
factors: 
1. Geographical & environmental factors 
including salted fish, preserved food, and some herbal medicines 
2. Epstein-Barr vims (EBV) infection 
3. Genetic factors 
such as specific HLA haplotypes 
II a. Geographical & Environmental factors 
The Chinese style salted fish is one of the proposed dietary factors correlated 
with NPC (Ho, 1972, Huang et al, 1978). It was first noted in the fisher-folk people 
whose diets contained a high proportion of salted fish but lack of vitamin-rich food (Ho, 
1967). This was further confirmed by a study of feeding salted fish to mice which 
resulted in the development of NPC (Huang et al, 1978). Case-control studies have 
suggested that childhood consumption of salted fish (particularly at weaning stage) is the 
primary cause ofNPC among Cantonese (Yu et al, 1989). The carcinogenic components 
identified in salted fish include volatile nitrosamines, particularly N-
nitrosodimethylamine and N_nitrosodiethylamine, as well as the N-nitrosodi-n-
propylamine and N-nitroso-n-butylamine that were present in cooked salted fish or its 
soup (Huang, 1991, Yu et al, 1988). Nitrosamines can be converted to an active 
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carcinogenic metabolites through nitrosation process (Poirier et al, 1989). These 
carcinogenic metabolites are suspected to be involved in damaging DNA or genomic 
instability, and have been implicated in the etiology of cancers of lung and upper 
respiratory tract (Hildesheim and Levine, 1993). In addition, shrimp paste, salted duck 
egg, fermented soy bean paste and some other kinds of Chinese preserved vegetables 
were also found to be possible dietary factors for NPC patients from eastem Guangxi 
(Yu et al, 1988, Yu et al, 1989). 
Some herbal medicines were suggested to associate with the development of 
NPC. These herbes contain tumor promoting agents such as phorbol esters and diterpene 
ester. The phorbol esters found in these medicines can reactivate the EBV or promote the 
vims transformed cells in vitro (Ito et al, 1981). Furthermore, occupation exposure to 
formaldehyde in wood dust, cooking fuel, antimosquito coils as well as cigarette 
smoking are some other possible etiologic factors ofNPC (Hildesheim and Levine 1993, 
Hirayama and Ito, 1981, Yu et al, 1988). 
NPC is regarded as a geographically specific malignancy. Chinese migrants 
living in low-incidence areas are found to have much higher incidence rate than the 
Caucasians. Studies found that the second or third generation of Chinese migrants in 
U.S.A. and Canada have decreased incidence ofNPC compared to their parents or home-
land Chinese (Yu et al, 1981, Burt et al, 1992). However, their incidence rate is still 
higher than the local low incidence populations (Yu et al，1981). This suggested that 
factors other than geographical differences are important to the development of NPC. 
The different genetic composition among various racial groups is suspected to be a 
possible reason of different NPC incidence (Hildesheim and Levine, 1993). 
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II b. Epstein-Barr virus Infection 
Epstein-Barr vims (EBV) is a gamma herpes vims which is a member of the 
human herpesvirus family (Liebowitz, 1994). Seroepidemiologic studies illustrated that 
EBV was widely spread in all human populations, with most adults were detected to 
have antibodies to the vims (Henle et al, 1970, 1979). Primary infection with EBV can 
occur in childhood without clinical manifestations or manifest as infectious 
mononucleosis in adolescents and adults (Liebowitz and Kieff, 1993). During primary 
infection, EBV infects B lymphocytes and persists in latent form. The virus can stay in 
an infected individual for the rest of the life in a small number of circulating B-
lymphocytes from a seropositive individual (Gerber et al, 1972). EBV infection o f B 
lymphocytes is important in the dissemination of infection to distal epithelial surfaces 
(such as nasopharynx), and in continuous reseeding the oropharyngeal epithelium 
(Liebowitz and Kieff, 1993, Li et al, 1994). 
EBV has been linked to a number of malignancies like Burkitt's lymphoma, 
Hodgkin's disease and NPC (Liebowitz and Kieff，1993, Sixbey et al, 1984). Virus 
infection of epithelial cells and B lymphocytes engenders a broad immune response, first 
by natural killer cells and later by HLA class I restricted EBV-specific, cytotoxic, or 
suppresser T lymphocytes and by antibody-secreting B lymphocytes (Liebowitz, 1994, 
Moss et al, 1992). 
The association of EBV with NPC was first suggested by a series of 
seroepidemiologic studies which demonstrated elevated antiviral antibody titers in NPC 
patients (Henle et al, 1970, Old et al, 1966). Elevated immunoglobulin G (IgG) and IgA 
antibody titers against viral antigens were frequently observed in patients with NPC, 
particularly the prevalent type of undifferentiated NPC in Southern Cantonese (Henle 
and Henle, 1976, Desgranges, 1977, Zeng et al, 1986). EBV receptors are also found in 
human pharyngeal epithelial and NPC cells (Young et al, 1986). EBV infects the 
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nasopharyngeal epithelium usually early in life. Later on, DNA-DNA hybridization and 
in situ hybridization studies showed the regular presence of the EBV DNA in NPC 
tumor cells. NPC biopsy materials were illustrated to have EBV infection by EBV 
nucleic acid hybridization studies fNfonoyama et al., 1973, Wolf et al., 1973, Klein et al., 
1974,). Southern blot hybridization demonstrated that EBV DNA in NPC biopsies is 
clonal and arising from a single EBV infected cell (Klein et al, 1974). Since that time, all 
histologically confirmed WHO II/III NPC cases have been detected to be EBV genome-
positive irrespective of the geographical or racial background of the patients (Klein, 
1979, Niedobitek, 1991). 
The EBV genome is a double stranded DNA molecule which exists as a linear 
molecule within the virus. It is transported to the nucleus and circularizes upon infection 
of a target cell (Liebowitz, 1994). There are two sub-types ofEBV (EBV-1 and EBV-2) 
circulating in most human populations (Abdul-Hamid et al，1992). Most NPCs of 
South-east Asia are reported to be undifferentiated type which are consistently EBV-
positive with the prevalent strain of type 1 EBV (Chen et al, 1992, Raab-Traub, 1992). 
The series of latent genes expressed in these virus are EBNA-1, EBNA-2 and EBNA 
3A/3C which are in the RNA level, as well as the LMP-1 and LMP-2 that are in the 
protein level (Liebowitz and Kieff, 1993). The latent gene expression series of type 1 
EBV include EBNA-1, LMP-1 and LMP-2. 
NPC cells are one of the kinds of EBV infected cells that express high levels of 
the EBERs transcripts. EBERs refer to the EBV-encoded small RNAs which are two 
small, nonpolyadenylated, palindromic DNAs transcribed in latent or productive 
infection (Brooks et al, 1992, Liebowitz, 1994). These RNAs can be used as markers of 
latent EBV infection in epithelial cells with the technique ofEBERs in situ hybridization 
(Gilligan et al, 1991). In our laboratory, this is one of the most commonly used tool for 
detecting the presence ofEBV in cells, such as in cell-666. 
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It is suggested that EBV is present within the cells at the time of carcinogenic 
transformation (Liebowitz, 1994). To reach their full malignant potential, the EBV 
infected nasopharyngeal cells may acquire additional cellular genetic changes such as 
exposure of environmental carcinogens and involvement of oncogenes or tumor 
suppresser in chromosomes. (Liebowitz, 1994). 
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II c. Genetic Factors 
HLA Susceptibility 
Human Leukocyte Antigens (HLA) is the genetic system that is frequently 
suggested to play a role in the etiology ofNPC. Different ethnic groups have their own 
characteristic haplotypes. HLA are located on the short arm of chromosome 6. HLA 
system is the Major Histocompatibility Complex (MHC) of humans. Products of these 
genes can control the recognition of a cell by antigen-specific cytotoxic T lymphocytes 
and have been implicated in the rejection of intracellular parasites, tumors, and tissue 
allografts (Browning et al, 1993). Loss of expression ofHLA molecules was proposed 
to present a mechanism with which a tumor cell can escape from immune surveillance 
by cytotoxic T lymphocytes that results in the immunoselection of the mutant cells 
(Browning et al, 1993). 
Studies concerning the association of HLA and NPC are mostly the investigation 
of class I HLA (Hildesheim and Levine, 1993). The association between specific HLA 
antigens and NPC was first reported in a study illustrating an excess ofA2 but deficit of 
Al l and Bw46 in NPC patients (Simons and Shanmugaratnam, 1982). Further 
evidences of HLA susceptibility came from the report of high frequencies of NPC in 
southern Chinese immigrants living in low incidence areas of South-East Asia, 
California and other areas of USA (Shanmugaratnam, 1973, Buell, 1974). Case-control 
studies found that individuals with a family history of NPC have higher risk of 
developing this cancer (Sriampom et al, 1992, Henderson et al，1976). Another study 
showed that increased risk of NPC associated with specific haplotypes in the HLA 
region included A2, Bw46, Bw59 and DR9 together with the mutation of DR3 (Chan, 
1990). This same study also suggested that the haplotype A2-Cwll-Bw46 with DR9 
missing was associated with older onset NPC patients, where Aw3 3 -C3-Bw5 8/DR3 
haplotype was found in younger onset and with a poor prognosis. Point mutations of 
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HLA-DR3 was detected and was suggested to affect the DR3 gene haplotype in 
producing specific cellular-mediated immunity towards the Epstein-Barr vims infection 
(Mellins et al, 1990). 
Our laboratory have examined the HLA profile ofhealthy subjects and a group of 
NPC patients in order to determine whether the HLA system plays a role in NPC patients 
in Hong Kong. The HLA class I (A2, A9, A11) and class II (DR3) alleles of 99 patients 
and 22 healthy controls were investigated with the technique of PCR with sequence-
specific primer combinations. However, the results were different from the previously 
reported data. In the study, NPC patients and healthy controls have similar frequencies of 
A2. A deficit of A l l and excess of A9 were identified in patients, but the differences 
between patients and healthy controls were not statistically significant. HLA-DR3 was 
found to be significantly higher in NPC patients when compare to healthy controls 
(unpublished data, 1995). More healthy controls are proposed to further investigate the 
association ofHLA and NPC. 
On the other hand, several cytogenetic analysis and molecular genetic studies 
have been conducted to investigate the carcinogenesis of NPC. The following chapters 
will discuss the cytogenetic and molecular genetic studies ofNPC. 
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IIL Cytogenetic Studies ofNPC 
III a. Traditional Cytogenetics 
The small size of biopsy that can be obtained is always a limitation for NPC 
investigations. Attempts have been done to provide more tumor sources and different 
models to study the pathogenesis of this cancer. Growing transferable subcutaneous 
tumors in athymic mice have been set up as in vivo models. Establishment of well-
characterized cell lines derived from NPC biopsies are good in-vitro systems for further 
investigation of the genetic mechanisms. 
Cytogenetic studies of a particular cancer provide a gross and complete 
investigation of chromosomal aberrations involved in that cancer (Solomon and 
Goddard, 1991). One advantage of cytogenetic analysis is that it can show abnormalities 
of both the chromosomal numbers and structures. Karyotypings allow the investigation 
of both the numerical chromosomal abnormalities (gains or losses of chromosomes), as 
well as common structural aberrations (such as rearrangement of chromosomes, 
segmental duplications or deletions, translocations，isochromosome, ring chromosomes, 
inversions, etc.). This is done by analyzing mitotic cells either directly from tumor 
specimens, or from the short-term (usually the primary culture of tumor tissues) or long-
term culture of tumor tissues (refereed to cell lines). The cell lines are usually 
established from the tumor tissues and further passage in in-vitro systems. 
The long-term culture of cell lines has the disadvantage of inducing in vitro 
changes during consecutive passages that may not be representative of the primary tumor 
specimen. Cytogenetic analysis of direct culture of primary tumor tissues can give a 
more accurate reflection of the chromosomal abnormalities involved, but without the in-
vitro selection pressures. However, there are many technical difficulties in direct culture 
oftumor tissues. These include lack of optimum and consistent culture conditions which 
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favor the culturing of epithelial cells. The culture conditions for direct culture can be 
very different each time, even for tumor of the same kind (Jin et al., 1993). Furthermore, 
the poor quality of metaphase morphology always makes analysis work impossible 
(Carey, 1995; Field, 1996). On the other hand, optimal culture conditions of cell lines 
are easier to obtain. Cell lines are also able to provide better quality karyotypings for 
detail analysis. 
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III b. Previous cytogenetic findings of NPC 
Due to the technical limitations of culturing solid tumors, only a few NPC 
cytogenetic studies had been reported. Previous cytogenetic analysis of both NPC 
xenografts and cell lines had revealed several chromosomal abnormalities in this tumor. 
The karyotypings of the well-characterized NPC xenografts and cell lines are illustrated 
in Table 2.1 and 2.2 respectively. 
Cytogenetic findings ofNPC were first reported in two xenografts (Mbane & Ali 
bin Ali) which were established from the malignant epithelial cells oftwo African NPC 
patients (Mitelman et al, 1983). Later on, cytogenetic studies of other xenografts (Xeno-
1 & Xeno-2) that were derived from the fresh biopsies of undifferentiated NPC were 
reported in Hong Kong (Huang et al., 1989). Karyotypes of another three xenografts 
(C15, C17 and C19) which originated from Africa and Europe were also investigated 
(Bemheim et al., 1993). These xenografts shared some common chromosomal 
abnormalities only, and most of the identified abnormalities were different. The most 
frequent abnormalities (appeared in at least four of the seven xenografts) are identified in 
chromosomes 1, 2，3, 6, 8, 9, 11, 14, 16 and 21. Trisomy one was identified in Xeno-1 
and Xeno-2 (Huang, 1989). Both Xeno-2 and C15 demonstrated gain of an extra 
chromosome 2 (Huang, 1989, Bemheim et al.，1993). One extra copy ofchromosome 8 
was found in Xeno-1 and Xeno-2, where monosomy 8 was identified in C17 and C19 
(Huang, 1989, Bernheim et al., 1993). Xeno-1 and Xeno-2 both consisted of trisomy 
nine (Huang, 1989). Loss of one chromosome 11 was found in C19 and Ali bin Ali 
(Mitelman et al,1983, Bemheim et al, 1993). Monosomy 14 was present in C17, C19 as 
well as Ali bin Ali (Mitelman et al,1983, Bemheim et al, 1993). Finally, C17 and C19 
illustrated consistent monosomy 16 (Bemheim et al, 1993). Besides these common 
abnormalities, there are also some important chromosomal abnormalities identified in 
the xenografts that are important to the pathogenesis of NPC. Of particular interest are 



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































del(9)(p) in C19 and monosomy 9 in C17 (Huang et al,1989, Bemheim et al,1993). 
These findings are parallel to the molecular studies of the chromosomes 3, 9, and 11 (Lo 
et al,1994, Huang et al,1994, Hui et al, 1996). 
CNE-1 (CNE) and CNE-2 are the two earliest reported NPC cell lines derived 
from well differentiated NPC and poorly differentiated NPC respectively (Zhang et al, 
1982, Zhang et al, 1983). Karyotypings of TW039 and its subline were also reported 
(Tien et al., 1990) in Taiwan. Later on, another seven NPC cell line NPC-TW03 to 
NPCTW09 were studied (Lin et al，1993). Karyotypings of cell lines are much more 
complicated than the xenografts both numerically and structurally. Each of these cell 
lines has their specific chromosomal abnormalities. However, all of them are hyper-
diploid. This may be due to the chromosomal alterations induced by in-vitro system. 
The two shared aberrations that have been identified in the CNE-1, CNE-2, NPC-TW03, 
TW039 and its lines are i(8q) and i(13q) (Zhang et al, 1982, Zhang et al,1983, Tien et al, 
1990, Lin et al, 1993). Another common alteration is del(X)(q24) which had been 
illustrated in NPC-TW03, as well as cell line TW039 and its subline (Tien et al, 1990, 
Lin et al, 1993). 
There is another cytogenetic study being conducted on NPC biopsies (Kristensen 
et al, 1991). They have analyzed 14 out of the 74 biopsies and reported to observe 
frequent appearance of a derivative chromosome 5 (5q+) with break point located at 
around 5q31. 
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III c. Fluorescence in-situ hybridization 
Cytogenetic studies have some limitations in the analysis of genetic changes. 
Firstly, the process which includes culturing of cells, harvesting mitotic cells and 
analyzing steps requires expertise to handle. They are labor intensive and time 
consuming. Secondly, only obvious and large alterations can be identified in the 
karyotypes. Some chromosomal rearrangements, as well as small chromosomal changes 
such as deletion or amplification of a small chromosomal fragment may not be scored 
(Carey, 1995). Ambiguous interpretation of microchromosomal changes may arise from 
either the poor quality of metaphases or the cytogeneticist's subjective opinions (Carey, 
1995). However, other more advance techniques such as fluorescence in-situ 
hybridization (FISH) and comparative genomic hybridization (CGH) have been 
developed to overcome these problems (Kallioniemi et al, 1993, Cowan, 1994, Fox et al, 
1995). 
The technique of FISH is fast and simple compared to the traditional cytogenetic 
studies. It involves adding a probe of interest to the chromosome preparation (in situ). 
The slide is allowed to undergo hybridization for the probe to match with the target. It is 
followed by washing and then detection (Cowan, 1994，Delellis，1994). There are many 
different kinds of probes in FISH. Some examples of which are total chromosome 
probes, unique sequence DNA probes and satellite probes such as centromere probes, 
telomere probes, alpha^eta satellite probes, etc. (Cowan, 1994). These probes are 
usually labeled with biotin or digoxigenin. With the addition of detection reagents, one 
can visualize the signals. Hence, even the less experience individuals can do the analysis 
work. 
FISH allows analysis of both interphase and metaphase spreads. Total 
chromosome probes are usually applied for chromosomal identification, confirmation of 
translocations and gross structural characterization of metaphases. Satellite probes are 
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used for chromosome identification and documentation of loss or gain of chromosomes. 
Unique sequence probes are applied for identification and refining structural 
characterization. Both of these two types of probes can be used for analysis of 
metaphase and interphase preparations (Cowan, 1994). Moreover, probes can be 
combined together to form cocktails and used in experiments that required internal 
controls. Hence, even in poor quality metaphases and samples which are hard to obtain 
metaphases, FISH still allows the analysis work to be done. Analysis of interphase 
spreads can be used to detect clonal markers of tumors (Carey, 1995). With the 
techniques of dual or multicolor FISH which use probes that are differently labeled, we 
can distinguish the different chromosomes involved in the chromosomal rearrangements 
(Fox et al, 1995). As a consequence, FISH is an important complement to the 
conventional cytogenetics in confirming the ambiguous results and characterizing 
unidentified marker chromosomes of cytogenetic analyses. In our study, the total 
chromosome painting probes of chromosomes 5, 6, 11, 12，14 and 18 were used to 
identify and confirm some of the ambiguous chromosomes found. 
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III d. The new NPC cell line: Cell-666 
As mentioned in previous sections, Epstein-Barr vims (EBV) infection is 
reported to be one of the important etiologic factors ofNPC. EBV is found to present in 
the xenografts such as xeno-1915, xeno-666 in our laboratory (unpublished data). 
Unfortunately, EBV was lost during continuous passages of the available cell lines 
which with cytogenetic analyses reported. Hence, we tried to establish an EBV 
associated NPC cell-line (cell-666) that derived from a primary undifferentiated NPC 
tumor growing subcutaneous in athymic nude mice. This cell line was found to have 
consistent presence of EBV by showing the presence of EBERs upon EBERs in-situ 
hybridization. Furthermore, aberrant methylation of 5'CpG island of p\6 gene in cell-
666 was also detected by molecular studies (Lo et al, 1995). It is believed to be an 
valuable modal for the study of NPC tumorigenecity. Attempts on cytogenetic analysis 
ofthis cell line had been conducted from passage #10. However, most of the trials were 
not successful due to the poor quality of chromosome spreads that cannot be analyzed. 
This may be resulted from un-optimized harvesting procedures, such as colcemid 
treatment time or KC1 concentration. Analyzable metaphase chromosomes were obtained 
until passage #15. Consequently, karyotypes of both earlier passage #16 and later 
passage #22 were conducted to compare the differences between these two passages. 
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IV. Molecular Genetic Studies in NPC 
Molecuiar genetic studies have been extensively performed to investigate the 
carcinogenesis ofNPC. Cancer is generally believed to be a mullet-step process which 
includes the three stages of initiation, promotion and progression (Pitot,1993). It is the 
result of an accumulation of multiple somatic mutations which are initiated by 
carcinogenic induced genetic damage in certain cells. If these mutations were not 
detected by the cell's DNA repair system, they will lead to development of a selective 
growth advantage for the growth of a tumor (Field, 1996). Oncogenes and tumor 
suppresser genes are two of the major molecular targets whose alterations result in 
neoplasia (Pitot, 1993). These two genes are two of the normal cellular genes which are 
important regulators in the normal cellular proliferation and differentiation. It has been 
reported that genetic alterations brought up by both oncogenes and tumor suppresser 
genes in tumor cell genome can act together to result in the progression of many tumors 
to full malignancy (Sikora, 1994, Strohmeyer and Slamon, 1994). 
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IV a. Oncogenes 
Oncogenes were first discovered in the RNA tumor viruses of chickens, cats, and 
rodents (Sikora, 1994). These genes encode a series of molecular cogs that can control 
the growth of cells by transmitting signals from the cell surface to the nucleus (Sikora, 
1994). Protein products of proto-oncogenes are involved in cell growth and 
differentiation, as well as cell cycle and signal transduction (Strohmeyer and Slamon, 
1994). The proto-oncogenes are activated by dominant mutations and can be converted 
from a normal cellular gene to an oncogene by different submicroscopic events such as 
point mutations, insertions and deletions, justaposition to other chromosome sequences, 
or translocations (Strohmeyer and Slamon, 1994). Mutations of proto-oncogenes lead to 
the production ofoncogene products with increased activity or excess production. These 
alterations can change the oncogenes' physiological function and result in uncontrolled 
or neoplastic cell growth. This may lead to the development of abnormal growth patterns 
and cancer (Strohmeyer and Slamon, 1994). The involved genetic alteration include 
changes at the DNA, RNA and protein levels which can be detected by different 
recombinant DNA techniques or immohistochemistry analysis (Pitot, 1993). 
The genes c-myc, ras and bcl-2 are three of the common oncogenes that have 
been identified to be associated with the carcinogenesis of many human cancers, c-myc 
gene encodes a nuclear protein ¢)62) and is capable of promoting proliferation and 
inducing apoptosis (Evan et al, 1992). The ras family genes encode a 21 kDa protein 
which with GTPase activity that involved in the signal transduction pathway leading to 
cell proliferation and transformation (Barbacid,1987). Gene products of bcl-2 can 
enhance cell survival by inhibiting apoptosis (Sun, 1995). 
Immunohistochemical studies demonstrated that overexpression but not point 
mutation of c-myc protein was found in 37/41 (90%) of primary NPC tumors (Porter et 
al, 1994). Another study using Northern blotting analysis found only overexpression, 
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but not rearrangement or amplification of c-myc in all of the investigated NPC cell lines 
(Lin et al, 1993). Moreover, overexpression of ras proteins were identified in 31/41 
(76%) of primary NPC tumors by immunohistochemical methods (Porter et al, 1994). 
Mutation of ras gene was not detected in primary NPC tumors with allele specific 
oligonucleotide hybridization and direct DNA sequencing methods (Sun, 1995). These 
results proposed that over-expression (but not point mutation) of ras and myc oncogenes 
may be important in NPC genesis. It was also suggested that c-myc expression with an 
unknown mechanism may be used as an independent parameter for disease prognosis 
(Sun, 1995). On the other hand, overexpression of bcl-2 was observed in most (80%) of 
NPC cells as illustrated by in-situ hybridization, immunohistochemical and 
immunoblotting techniques (Henderson et al, 1991, Lu et al, 1993). However, one ofthe 
previous studies reported no close correlation of bcl-2 expression with the presence of 
EBV DNA and LMP-1 expression (Lu et al, 1993). Expression of bcl-2 is detected in 
the basal compartment of normal nasopharynx epithelial cells. Hence, detection of hcl-2 
protein in NPC might reflect the cell origin and undifferential phenotype of the tumor 
cells, or indicated that bcl-2 may be upregulated by other unknown cellular or viral 
factors in the NPC cells (Lu et al, 1993). 
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IV b. Tumor suppresser genes (TSGs) 
In malignant cells, transforming capacity of proto-oncogenes require their gene 
products to be structurally or numerically altered. However, activity of TSGs requires 
their gene products to be inactivated or lost. TSGs are recessive that loss of their 
fUnction required both copies to be inactivated. This can be achieved through the 
genetic alterations like point mutations, protein-protein interactions, chromosomal 
deletions of the entire chromosomes or just the chromosomal region of the particular 
genes (Weinberg, 1991). Some studies proposed that genetic alteration of the first copy 
of a TSGs may play a critical role in the initiation stage. Further alteration of the other 
allele acts as the determinant in the transition from promotion to progression stage (Pitot, 
1993). The following table shows some existing tumor suppresser genes that have been 
widely investigated ( Skuse and Ludlow, 1995). 
Table 2.3 Illustration ofsome ofthe tumor suppressor genes. 
Chromosomal Gene Gene product Subcellular Function 
location location — 
^ —MSH2“™"""""MSH2 N u c l ^ DNA r e ^ 
3p MLH1 MLH1 Nucleus DNA repair 
3p VHL VHL Unknown Unknown 
5q APC APC Cytoplasm p-catenin binding 
9p pl6 pl6 Nucleus Kinase inhibitor 
l lp WT1 WT1 Nucleus Transcription factor 
13q Rb pRB Nucleus Transcription factor 
17p p53 p53 Nucleus Transcription factor 
17q NF1 Neurofibromin Cytoplasm GTPase activating 
protein (GAP) 
22q NF2 Merlin Cytoskeleton Integration of 
cytoskeleton with plasma 
membrane 
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Presence of tumor suppresser cells were demonstrated in several observations as 
briefly described in the following paragraphs (Knudson, 1971，Sager, 1985, Weinberg, 
1991, Strohmeyer and Slamon, 1994): 
a. Fusion ofamalignant and a non-malignant cell (with a complete set of chromosomes) 
results in suppression of the malignant phenotype in most cases. But the malignant 
phenotype reappeared in hybrids with loss of one or more chromosomes that come from 
their normal parent (Weinberg, 1991). 
b. Knudson's two-hit hypothesis suggested that two mutations must occur in the gene 
encoding a tumor suppresser before a tumor develops. Usually, one of the two mutations 
is inherited from a genetically afflicted parent or originates during gametogenesis. Then 
the second required mutation occurs as a spontaneous somatic event (Knudson, 1971). 
c. Finally, wild-type allele elimination was evidenced during the evolving oftumor cells. 
Normally, the first copy of suppresser gene is inactivated by somatic or germline 
mutations. Duplicated copy of this mutated copy may then knockout the normal wild-
type allele by processes like chromosomal nondisjunction, mitotic recombination or gene 
conversion. The TSGs then result in having two same copies of mutated alleles in 
tumors. This homozygosity of mutant suppresser allele favors the development of 
cancers (Sager, 1985，Strohmeyer and Slamon, 1994) 
Intercellular communication between cells is important for the growth 
encouraging or inhibiting of their neighboring cells. Products of TSGs function as 
transducers of negative growth signals that signaling the growth inhibition of their 
surrounding cells. TSGs have been reported to be genetic elements whose loss or 
inactivation allow a cell to display one or another phenotype of neoplastic growth 
deregulation (Weinberg, 1991). The exogenous signals can persuade cells to halt 
proliferating through the following routes (Stoker, 1967, Spom et al, 1986, Weinberg, 
1991): 
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1. Through the contact inhibition displayed by normal cells growing in 
monolayer culture. 
2. Using anti-mitogenic signals carried by diffusible growth inhibitors in gap 
junctional communication 
3. By hormones and macromolecular growth inhibitors that may be passed 
between cells. 
During normal situations, cells will stop growth or proliferation after receiving 
growth inhibiting signals (Weinberg, 1991). Firstly, cells in exponential growth may 
pause in one or another phase of its growth cycle by hold-up at the end ofthe G1 phase 
just prior to S phase for DNA synthesis. Cells can also be induced to undergo an end 
stage of the post-mitotic differentiation. Furthermore, cells may be induced to undergo 
senescence or apoptosis (which refers to aging or programmed death respectively) 
(Wyllie, 1980, Goldstein, 1990, Weinberg, 1991). 
Cancers ofdifferent tissues are developed through genetic alterations of a variety 
of genes that regulate cell division. Different tumors carried different mutant TSGs. 
Hereditary diseases that predispose to neoplasia have been proven to be excellent 
systems for identification of tumor suppressers (Skuse and Ludlow, 1995). Products of 
some TSGs are involved only in the development of tumors (such as pRb and WT1), but 
others participate in different phenotypic characteristics of disease (e.g. neurofibromin) 
(Weingberg, 1991, Skuse and Ludlow., 1995). Colorectal cancer is the most common 
cancer in studying TSGs, due to the involvement of multiple tumors in various stages of 
tumor progression. The Rb gene and p53 gene are the two most popular examples of 
TSGs. 
The retinoblastoma susceptibility gene {Rb) is one of the well characterized 
TSGs. It is the best example of a pure TSG which with a true loss-of-function mutation 
can lead to the development of tumors (Levine, 1993). On the other hand, p53 is a 
complicated example which loss of its function results in negative growth regulation, but 
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the altered or mutated protein allows the gain of some function (Levine, 1993). Reports 
proposed that loss or inactivation of one of the alleles of Rb or p53 usually occurs in the 
germline with subsequent inheritance of single functioning allele in all somatic cells 
(Cavenee et al, 1983, Levine et al, 1991). The second mutagenic event is somatic that 
can result in the inactivation of the remaining allele favoring the clonal evolution of cell 
and tumor formation (Loda, 1994). 
The Rb gene was mapped to chromosome 13ql4 (Friend et al, 1986). In 
retinoblastoma, both alleles of Rb gene are altered by mutation, or more commonly, one 
allele is mutant while the second allele is lost or reduced to homozygosity by a gene 
conversion or a recombination event (Cavenee et al, 1983). The gene encoded a 105 kDa 
nuclear phosphoprotein which plays a role in the regulation of cellular DNA synthesis 
(Lee et ai, 1987). It is involved in the restriction point control of progression through Gi 
phase to S phase of the cell cycle (Lee et al, 1987). Phosphorylation ofRb protein by the 
CDK/cyclin complex will release the E2F transcription factor to switch on the genes for 
DNA synthesis (Sherr et al, 1996, Chen et al, 1989). Deletions, point mutations or errors 
in splicing the mRNA are some of the mutations identified in Rb gene (Levine, 1993). 
Point mutations producing missense proteins in the regions between amino acid 393-572 
and 646-772 are thought to interact with other cellular proteins or viral oncogene 
products (Hu et al, 1990) It is suggested that point mutations in these regions may 
inactivate Rb function as a negative regulator of cell division (Levine, 1993). 
Study of carcinogenesis of NPC found no mutation at the coding region and 
exon-intron boundaries of Rb (Sun et al, 1993). Furthermore, neither promoter region 
deletion, nor gross rearrangement of Rb gene was identified by Southern blotting 
analysis (Sun et al, 1993). Another study of seven NPC cell lines detected only variable 
expression of Rb protein, but absence of deletion and abnormal rearrangements (Lin et 
al, 1993). These results proposed that normal Rb gene presents in almost all ofthe NPC 
samples and the potential significance of Rb gene alteration in NPC can be ruled out 
(Sun, 1995). However, alteration of another Rb family member gene pl30/Rb2 was 
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identified in a NPC derived cell line (Claudio et al, 1994). This study found that 
introduction of the cloned pl30/Rb2 cDNA to a NPC derived cell line can suppress the 
growth ofthe cells, and hence proposed a role of this gene in NPC tumorigenesis. 
p53 gene was located at chromosome 17pl3.1 which encodes a 53 kDa nuclear 
phosphoprotein that acts as a transcription factor (Benchimol et al, 1985). This gene is 
involved in many tumor types and has a pivotal role in regulating cell cycle progression 
(Levine et al, \99\).p53 gene plays an important role in arresting the cell cycle to permit 
repair ofdamaged DNA as well as inducing apoptosis if damage is irreparable. The loss 
of its function may result in genomic instability or accumulation of genetic lesions 
(Field, 1996). The wild type of p53 gene is a negative regulator of cell division and a 
tumor suppresser gene, but a missense mutation of this gene can produce a faulty protein 
product that appears to promote cell division under certain circumstance (Levine, 1993). 
p53 mutation was found to be a rare event in primary NPC tumors and EBV-
positive NPC xenografts, but missence mutations were identified in three EBV-negative 
NPC cell lines (Spmck et al, 1992). Another study had observed similar results that only 
1/22 (4.5%) ofNPC samples had the heterozygous mutation of the p53 gene (Sun et al, 
1992). Furtherp53 study ofNPC identified no mutations in the 18 investigated primary 
NPC tumors, but with p53 gene mutations in 2/15 metastatic tumors and 4/7 NPC 
xenografts that were derived from metastatic tumors (Effert et al, 1992). Although 
common in many human cancers,j^J5 mutation appears to be infrequent in primary NPC 
tissues. However, overexpression of the p53 gene was observed in immunohistochemical 
analysis (Porter et al, 1994, Sheu et al, 1995). One of the studies reported that 
overexpression of the p53 protein was found in 96/101 (95%) ofNPC samples (Sheu et 
al, 1995). They also suggested that p53 overexpression may occur at the early stage of 
NPC development. Furthermore, studies of other common TSGs found no p21/WAF 
mutations in primary NPC tumors and suggested that alteration of this gene was not 
likely to participate in NPC pathogenesis (Sun et al, 1995). 
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Several molecular genetic studies ofNPC have been reported. The frequent loss 
ofheterozygosity on chromosomes 3 or homozygous deletion detected on chromosomes 
9 indicated presence of putative TSGs that are important to the pathogenesis of NPC 
(Huang et al, 1991，Choi et al, 1993，Lo et al, 1994，Huang et al, 1994, Lo et al, 1995, Lo 
et al, 1996). Firstly, allelic loss of chromosome 3 was frequently detected in 18/27 
(67%) of primary undifferentiated NPC (Lo et al, 1994). Results also demonstrated that 
three regions (3pl3-14.3, 3pl4.3-21 and 3p21.3-pter) of allelic deletion were identified 
on the short ami of chromosome 3. Region 3pl3-14.3 showed the highest frequency of 
loss (Lo et al, 1994). More than one putative TSGs related to NPC are suggested to be 
located in chromosome 3p. Highest frequency of allelic loss was also detected at the 
locus D3S1038 in 3p25 (Lo et al, 1994). This locus is closely linked to von Hippel-
Lindau (VHL) disease TSG. However, further study using PCR-SSCP (single strand 
conformation polymorphism) and direct sequencing methods found no encoding region 
mutations in the investigated NPC tumors or cell lines (Sun et al, 1995). As a result, 
inactivation of VHL gene may not be involved in the NPC tumorigenesis. 
The short arm of chromosome 9p21-9p23 was investigated to have 11/18 (61%) 
of LOH in primary NPCs (Huang et al, 1994). Homozygous deletion at 9p21-22 was 
detected in one ofthe cases by multiplex PCR. This deletion region is also the location 
of the cyclin-dependent kinase-4 inhibitor genes, pl5 and pl6/MTSJ/CDKN2 (Field, 
1996). The two genes encode cell cycle regulator proteins (Kamb et al, 1994). pl6 
proteins can bind to CDK4 and CDK6 to prevent CDKs from forming active 
CDK7cyclin D complex. Inhibition of the CDK/cyclin D complex catalytic activity will 
stop the phosphorylation of Rb protein and hindered the cell cycle progression from Gi 
phase to S phase (Serrano et al, 1993, Huang et al, 1994). Afterwards, another study of 
thep l6 gene was conducted (Lo et al, 1995). It was found that mutation ofpl6 gene was 
only presented in NPC cell lines, and not in primary tumors or xenografts. However, 
homozygous deletion was detected in 2/3 (67%) xenografts and 7/20 (35%) primary 
tumors with multiplex PCR (Lo et al, 1995). Hence, alterations of the pl6 gene were 
proposed to be a frequent event in NPC with which homozygous deletion was the major 
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mechanism for the inactivation of the gene (Lo et al，1995). Furthermore, a study of 
aberrant methylation of the pl6 gene was also investigated in NPC (Lo et al, 1996). That 
study suggested that hypermethylation of the 5'CpG island may act as another 
mechanism ofpl6 gene inactivation by participating in the transcriptional inactivation of 
the pl6 gene (Lo et al, 1996). As a consequence, pl6 gene was suggested to play a role 
in the carcinogenesis ofNPC. 
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IV c. Loss of Heterozygosity Studies 
There are many different classical DNA analysis techniques that have been used 
to investigate the genetic alterations, such as Southern blotting, DNA sequencing and 
restriction fragment length polymorphisms (RFLP). But the Southern blotting method 
usually required large quantities of intact genomic DNA and is labor intensive. The loss 
of alleles, genes or gene fragments were originally illustrated by the application of 
RFLP. However, RFLP have the disadvantage of requiring the slow and laborious 
techniques of Southern blotting (Koreth et al, 1996). Development of advance 
recombinant DNA technique such as polymerase chain reaction (PCR) methods have 
greatly enhanced the application of these techniques. Nowadays, another PCR method 
with the use ofmicrosatellite polymorphic markers is frequently employed to investigate 
the incidences ofloss ofheterozygosity (LOH). 
Microsatellites are also called simple sequence length polymorphisms, or short 
tandem repeat polymorphisms (Koreth et al, 1996). It can be defined as tandem arrays of 
short stretches of nucleotide sequences, usually repeated between 15 and 30 times 
(Weber and May, 1989, Koreth et al, 1996). Microsatellites are member ofthe family of 
repetitive non-coding DNA sequences which are widely dispersed in the human genome 
(Weber, 1990). Its sequences array with a repeat size of 2-6 bp, highly variable in size 
but they range around a mean of lOObp. Microsatellites are found in the euchromatin 
and allele sizes in populations characteristically exhibit multiple size classes distributed 
in the population mean (Tautz and Rena, 1984). Microsatellite is not uniformly spaced 
along chromosomes but is underrepresented in regions near the telomeres (Tautz and 
Rena, 1984). The informativeness of microsatellites increases with increasing average 
number of repeats (Koreth et al” 1996). There are some advantages of microsatellites 
such as high heterozygosity, ubiquity through the genome (especially adjacent to coding 
sequences), and with PCR typability (Watson et al, 1992, Koreth et al, 1996). A variable 
locus is made up of a variable number of identical sequences joined together in tandem. 
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There are many different variable number tandem repeat loci in the genome, so that each 
individual has his unique pattem of fragments from the variable tandem repeat loci 
(Watson et al, 1992). Hence, the microsatellite PCR method is widely used in DNA 
fingerprinting for identifying individuals in medical and forensic applications. This 
technique is also the method frequently used in most allelotyping studies for identifying 
small regions of change. 
The repetitive sequences di-, tri-, and tetra-nucleotide repeats are abundant in 
human genome (Weber and May, 1989). The nucleotide repeat dA-dC or cytosine-
adenosine (CA)n is one of the most frequent sequence motifs in human microsatellites 
which range from 35000 to 100000 copies in the human genome (Weber, 1990). (CA)n 
dinucleotide repeats are located throughout the genome at intervals around once every 
50-100 kbp with difference in length on the matemal and patemal chromosomes 
(Watson et al, 1992). It is widely used in PCR based microsatellite polymorphism 
analysis by making use of the variable numbers of (CA)n tandem repeats in different 
alleles of genes. It can be analyzed quickly by PCR with primers complementary to 
unique sequences adjacent to the repeats. In informative cases, people who are 
polymorphic for a particular locus will have two different alleles with one from paternal 
and one from maternal chromosomes. These two alleles have different numbers of 
variable dinucleotide repeats at a particular gene or chromosomal region (Koreth, 1996). 
The technique of detection of LOH is frequently used for the identification of 
possible TSGs (Field, 1996). In the two-step inactivation of TSGs, point mutation o f a 
critical suppresser allele is followed by deletion of the second allele and total 
inactivation of tumor suppresser function. Thus, chromosomal deletion represent a 
common second inactivation step for a putative TSG within the deleted region 
(Sidransky, 1995). Hence, frequent presence of LOH within a particular chromosomal 
region in a specific tumor may indicate the presence of a tumor suppresser gene(s) 
involved in the development of this tumor. 
30 
After performing PCR with radioactive labeling method, the two polymorphic 
alleles will both be amplified and the products will have different base pairs. 
Electrophoresis which use the polyacrylamide gels can separate these two different 
alleles based on the sizes differences. After exposing the signals to X-ray films, we can 
then expect to detect two different bands representing the two polymorphic alleles of 
different molecular sizes. If the two alleles of that particular normal individual is 
polymorphic, cases with no allelic loss will show two different bands in the 
corresponding DNA samples. However, PCR product of tumor sample will have one of 
the bands missing. In samples with normal contamination, there will be diminishment in 
the signal intensity of one ofthe bands. In our study, comparisons are usually carried out 
by comparing the constitutional DNA of one's peripheral blood (which are supposed to 
be normal) with the DNA of the tumors. As a result, The frequent detection ofLOH o fa 
particular DNA marker in cells from a specific tumor type usually indicates the presence 
of certain putative tumor suppresser gene or genes in nearby chromosomal regions. And 
loss of these TSGs may lead to the development of this cancer (Weinberg, 1991). 
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IV d. LOH on Chromosome 11 
LOH on chromosome 11 is one of the common genetic alterations found in many 
tumors. LOH on the short arm of chromosome 11 had been observed in many types of 
cancers. One of the TSGs, the Wilm's tumor gene {WT1), has been identified to be 
located at chromosome l lp l3 (Riccardi et al, 1978). The chromosomal region l lp l5 
was found to demonstrate high frequency ofLOH in some tumors such as breast cancer, 
adenocarcinoma of the stomach, and bladder carcinoma (Winqvist et al, 1995, Baffa et 
al, 1996, Shaw and Knowles, 1995). This indicates the presence of putative TSG(s) at 
this specific region. Evidences also suggested a second Wilm's tumor locus at l l p l5 
(Levine, 1993). Recently, a tumor susceptibility gene TSG101 which was mutated in 
breast cancers was identified to be located in chromosome 1 lpl5.1-15.2 (Li et al, 1997). 
Region l lq l3 was also found to demonstrate LOH in some tumor types. LOH 
study in microdissected in situ and invasive human breast cancer observed a high 
frequency of LOH in 1 lql3 and suggested the presence of TSG(s) in this region, which 
are involved in the development of this cancer (Zhuang et al, 1995). The putative MEN1 
(multiple endocrine neoplasia type 1) TSG was linked to chromosome l lq l3 (Bystrom 
et al, 1990, Radford et al, 1990). High frequency of LOH was detected in MEN-1 
patients (Lubensky et al, 1996). 
On the other hand, amplification has also been identified in chromosome l lql3. 
These include the genes INT2/FGF3, HSTl/FGF4, BCL1, CCND1/PRAD1 and EMSI, 
which are amplified in about 30-60% of head and neck squamous cell carcinomas 
(HNSCC) (Lese et al, 1995).). CCND1/PRAD1 was proposed to be a regulator ofearly 
cell division cycle events and play a role in neoplasia (Dickson et al, 1995). 
Amplification of the Int-2 gene was illustrated in 30-50 % of another study of HNSCC 
(Somers et al, 1990). Moreover, amplification ofINT2/FGF3 and CCND1/PRAD1 was 
also reported to play an important role in local relapse of breast cancer (Champeme et 
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al, 1995). The gene of the adult high-affinity folate receptor {F0LR1) was found to map 
to region llql3.3-13.5 and reported to be amplified in ovarian cancer ( Foulkes, et al, 
1993). 
Regions of LOH at the telomeric part of chromosome 1 lq are frequently reported 
in different types of solid tumors such as breast, ovarian, colorectal cancers, and 
adenocarcinoma of lung. The following table summarizes the results of LOH studies of 
the aforementioned tumors. 
Table 2.4 Results ofLOH studies in different tumors. 
Cancer type Regions showing LOH # of deletion regions 
Breast cancer llq23 2 
Lung adenocarcinoma llq22-24 3 
Cervical cancer llq22-24 1 
Stomach adenocarcinoma llq22-23 1 
Ovarian cancer llq23.3-24.3 2 
Bladder cancer 1 lql3-23.2 1 
Breast cancer study showed at least two independent regions at llq23 are 
commonly deleted (Negrini et al, 1995). One of these regions is bracketed by loci 
D11S2000 and D11S897 which defines an area of less than 10 Mb that includes the 
ATM locus. LOH study of lung adenocarcinoma identified three independent regions of 
deletion on the long arm of chromosome 11, between markers DllS940-CD3D, 
D11S924-D11S925 and D11S1345-D11S1328 (Rasio et al, 1995). Some previous 
studies of cervical carcinoma also proposed a suppresser gene(s) being mapped to 
chromosome llq22-q24 (Hampton et al, 1994). A minimal critical region of LOH at 
llq22-23 was identified in adenocarcinoma of the stomach (Baffa et al, 1996). 
Epithelial ovarian cancer with a large centromeric region of LOH between D11S35-
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D11S933 and a telomeric 8.5Mb region between D11S934-D11S1320 were found to be 
associated with poor prognosis (Gabra et al, 1996). In bladder carcinomas, a common 
region of deletion was mapped to llql3-23.2 between FGF3 and D11S490 (Shaw and 
Knowles, 1995). 
Besides ATMgQm, the ALL-1 gene was also found to be located at chromosome 
1 lq23. Translocation of this gene is frequently involved in acute lymphoblastic leukemia 
and acute myeloid leukemia. However, involvement of ALL-1 gene was identified in a 
study of gastric carcinoma cell line (Baffa et al, 1996). They found no functional wild-
type allele of ALL-1 gene in the cell line and suggested that this gene may involve in 
tumorigenesis by a loss-of-function mechanism. 
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IV e. ATM Gene 
The 1 lq22-23 genome region was found to coincide with genomic location ofthe 
ATMgQYiQ that is involved in the cancer-predisposing, DNA repair deficiency syndrome, 
Ataxia-telangiectasia (AT) (Gatti et al, 1991). AT is an autosomal recessive genetic 
disorder. This disease has no obvious DNA repair defect (Jorgensen and Shiloh, 1996). 
AT is characterized by cerebella degeneration, immunodeficience, chromosomal 
instability, cancer predisposition, radiation sensitivity and cell cycle abnormalities 
(Sedgwick and Boder, 1991, Savitsky et al, 1995). Although AT is rare, heterozygous of 
AT gene mutations (with single copy of the defective gene) are present in around 1% of 
the population (Savitsky et al, 1995). Individuals with heterozygous for AT illustrated 
the disease characteristics of cancer predisposition and radiation sensitivity. This AT 
heterozygous also gives women a five-fold increase of breast cancer ( Swift et al, 1987, 
Savitsky et al, 1995). 
Four complementation groups (A, C, D & E) have been described for the 
classical form of this genetically heterogeneous disease (Mumane and Painter, 1982). All 
ofthese complementation groups map to chromosome 1 lq23 and have been suspected to 
represent different genes. However, the ATM gene is found to be mutated in AT patients 
from all complementation groups and is proposed to be the sole gene responsible for AT 
(Savitsky et al, 1995). This gene spans around 150kb of genomic DNA and generates a 
12-kb transcript (Uziel et al, 1996, Savitsky et al, 1995). It has been identified by 
linkage analysis to be located in chromosome 11 at the region q22-23 (Gatti et al, 1991). 
ATM gene is reported to be not only the causes of the rare hereditary disorder AT, but 
may also be the largest hereditary cause of breast cancer (Jorgensen and Shiloh, 1996). 
The risk of cancer in patients with AT is about 100 times higher than in the non AT 
populations (Morrell et al, 1986). 
35 
The caiboxyl terminus of the ATM complementary DNA clone encoded a 
putative protein homology which shows high similarities to the lipidkinase domain of 
the 110-kDa catalytic subunit of phosphatidylinositol-3 (PI-3) kinase that are involved in 
mitogenic signal transduction, meiotic recombination and cell cycle control (Savitsky et 
al, 1995). PI-3 kinase is a signal transduction mediator in mammalian cells which 
mediates cellular responses to several mitogenic growth factors, to factors triggering 
cellular differentiation, and to insulin (Divecha and Irvine, 1995). Suggestions proposed 
that ATM gene product is member of a human TI-3 kinase-like' signal transduction 
family (Meyn, 1995). This family of transducing proteins is novel that it responds to 
DNA damage signals originating in the cell nucleus rather than the cell membrane, and 
transmits these signals downstream to enzyme pathways associated with maintenance of 
genomic stability and cell viability, including protection against ionizing radiation 
(Jorgensen and Shiloh, 1996). ATM gene is then suggested to be involved in signal 
transduction, cellular responses to DNA damage, and cell cycle control (Savitsky et al, 
1995). AT protein may be a link in the signal chain that tells the cell to stop dividing so 
that the DNA damage can be repaired. The ^rAfprotein is also similar to another group 
ofprotein that include the yeast proteins rad3, and MEC1/ERS1, whose job is to block 
the cell cycle in cells with which DNA has been damaged by ultraviolet radiation or X-
rays (Jorgensen and Shiloh, 1996). Its resemblance to the yeast proteins suggested that it 
may help cells to recognize damaged DNA so that it can be repaired before the cells 
divide (Zakian, 1995, Jorgensen and Shiloh, 1996). 
The DNA Damage Surveillance Network model suggested that lack of a 
functional ATMgQnt results in an inability to: 1) halt at multiple cell cycle checkpoints 
in response to DNA damage; 2) activate damage-inducible DNA repair; and 3) prevent 
the triggering of programmed cell death by spontaneous and induced DNA damage 
(Meyn, 1995). The absence of damage-sensitive cell cycle checkpoints and damage-
induced repair disrupts immune gene rearrangements may lead to genetic instability and 
cancer (Meyn et al, 1994). Moreover, the radiation sensitivity of AT homozygotes is 
suspected to be caused by the triggering of apoptosis by non-lethal DNA damage (Meyn, 
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1995). This will result in an ongoing loss of cells which lead to cerebellar ataxia and 
neurological deterioration, lymphocytopeia, athymic atrophy and a paucity of germ cells 
(Meyn, 1995, Jorgensen and Shiloh, 1996). 
Furthermore, the ATM gene was identified to be upstream of the p53 gene in a 
pathway that activates a Gi_S checkpoint (Rasio et al, 1995). Inappropriate p53-
mediated apoptosis was detected to be the major cause of death in AT cells irradiated in 
culture (Meyn et al, 1994). AT cells showed a delay in the increase ofp53 levels after 
gamma irradiation (Lu and Lane, 1993). It is suggested that a normal function of the 
wild-type ATM protein may interact with the p53 protein and inhibit the jc>5i-mediated 
activation of apoptosis (Meyn, 1995). This may promote survival of cells that have 
sustained DNA damage. Alternatively, the ^rMprotein may indirectly counteract p53-
mediated apoptosis by inhibiting a step in apoptosis that is downstream of p53 (Meyn, 
1995). ATM gene is proposed to act like other TSGs that its inactivation might occur 
during tumor progression and be detected as LOH of markers near the ATM gene on 
llq23 (Meyn, 1995). LOH at llq22-23 loci is a frequent event detected in several 
common cancers such as lung adenocarcinoma, breast cancer, ovarian cancer, etc. (Rasio 
et al, 1995, Negrini et al, 1995 and Davis et al, 1996). Hence, as observed in the LOH 
studies, loss of ATM function might play a critical role in the development of these 
cancers (Meyn, 1995). 
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CHAFim 2 
OBJECTIVE OF S T U D Y 
Nasopharyngeal Carcinoma O^PC) is a common cancer in South-east Asia. 
Hong Kong is one of the high incidence areas. The carcinogenesis ofNPC is reported to 
be a multistep process that involves interactions between several different factors. The 
etiology of this cancer has been suggested to be associated with geographical and 
environmental factors, Epstein-Barr virus infection, and some genetic factors 
(Hildesheim and Levine, 1993). Extensive studies of the association of these etiologic 
factors with NPC have been widely investigated by many research groups. However, the 
molecular mechanisms in the pathogenesis ofNPC are still not well understood. In this 
study, we intend to investigate the chromosomal abnormalities involved in NPC, 
particularly for chromosome 11, using both cytogenetic and molecular approaches. 
Oncogenes and tumor suppresser genes (TSGs) are two of the major molecular 
targets whose alterations are suggested to result in the development of cancer. Previous 
molecular genetic investigations on NPC detected frequent allelic loss at chromosome 
3pl3-14.3 and 9p21-23 (Huang et al, 1994, Lo et al, 1994). These results indicate the 
presence of putative tumor suppresser genes (TSGs) which are associated with 
carcinogenesis ofNPC at these chromosomal regions. The techniques used in the above 
studies are PCR methods with the use of microsatellite polymorphic markers. It is a 
common method for detecting loss ofheterozygosity (LOH) at a particular chromosomal 
region. Frequent presence of LOH within a specific chromosomal region in a specific 
tumor may indicate the presence ofTSG(s) in nearby areas (Koreth, 1996). 
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LOH on the long arm of chromosome 11 is one of the common genetic 
aberrations reported in many solid tumors such as breast cancer, ovarian cancer, cervical 
cancer, etc. (Hampton et al, 1994, Negrini et al, 1995, Gabra et al, 1996.). Chromosome 
1 lq has been reported to be one of the regions that frequently showing allelic imbalance 
in squamous cell carcinoma of the head and neck O^awroz et al, 1994). Multiple 
independent regions showing LOH was detected in breast cancer and lung 
adenocarcinoma (Rasio et al, 1995, Negrini et al, 1995). This suggests the presence of 
multiple putative TSGs on chromosome 1 lq which may participate in the carcinogenesis 
of these cancers. Moreover, rearrangement of chromosome l l q has been demonstrated 
in the cytogenetic analysis ofNPC xenografts (Huang et al, 1989). To further investigate 
the association of this abnormality with NPC, we will study the LOH pattem of 
chromosome l lq in 51 NPC tumors. In this study, eleven microsatellite polymorphic 
markers mapped to the long arm of chromosome 11, and one marker mapped to the short 
arm will be investigated. 
On the other hand, cytogenetic and karyotype analysis of a particular tumor 
allows the detection of the macroscopic and overall investigation of chromosomal 
aberrations involved in a cancer. In karyotype analysis, we can identify both structural 
and numerical chromosomal abnormalities. Cytogenetic analysis of both NPC 
xenografts and cell lines have revealed several chromosomal abnormalities in this tumor 
(Zhang et al,1982, Zhang et al,1983, Mitelman et al,1983, Huang et al,1989, Tien et 
al,1990, Bemheim et al.，1993). Very few cytogenetic analyses of NPC have been 
reported due to the technical difficulties of culturing solid tumors. Cell lines are good in 
vitro models of studying pathogenetic mechanisms of cancers. However, most of the 
available NPC cell lines were found to have lost EBV during continuous passage. A 
long term cultured NPC cell source (cell-666) has recently been established in our 
laboratory. Cell-666 has been passaged for 45 times at the time ofpreparing this thesis. 
It is derived from a primary undifferentiated NPC tumor growing subcutaneously in 
athymic nude mice. Cell-666 has been illustrated to harbor the EBV genome by 
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showing consistent presence of EBERs upon EBERs in-situ hybridization. Aberrant 
methylation of5'CpG island of pl6 gene has also been detected in these cells (Lo et al, 
1996). We propose to perform the karyotype analysis of cell-666. To confirm some of 
the identified chromosomal abnormalities, we have used the technique of Fluorescence 
in-situ hybridization (FISH) with total chromosome probes. 
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CHAPTER 3 
M A T E R I A L S AWD METHQDK 
•: Study of loss of heterozygosity on chromosome 11 
I a. Patients and Specimens 
Primary nasopharyngeal carcinoma biopsies from 51 patients were obtained prior 
to treatment: 9 of theses patients' specimens were provided from Cancer Institute, Sun 
Yat-Sen University of Medical Sciences Cancer Center at Guangzhou, China, and 42 
were from Prince ofWales Hospital, the Chinese University ofHong Kong, Hong Kong. 
Figure 3.1 and 3.2 a & b showed the information ofthe 9 NPC patients from the Sun 
Yat-Sen University ofMedical Sciences Cancer Center, and the 42 patients form Prince 
ofWales Hospital respectively. Corresponding blood samples of patients were included 
as controls. The blood samples were stored in a -70�freezer, immediately after 
collection, for later DNA extraction. High molecular weight DNAs were extracted from 
both the tumor and the blood samples according to conventional methods recommended 
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I b. DNA extraction 
I. Blood samples 
DNA extraction of all of the blood samples were conducted with the same 
method. To start DNA extraction, the frozen blood samples were first thawed at 37°C 
water bath and transferred to 15ml conical tubes (Falcon, New Jersey, USA). Removal 
of haemoglobin was done by add in equal volume of 1 X PBS (phosphate buffered 
saline, from Sigma, St. Louis, USA) to each tube and mixed well. The supernatant was 
discarded after centrifuging at 3200 rpm for 20 min. 40|ul of lOmg/ml Proteinase K 
(Sigma, St. Louis, USA) along with 4ml pH7.4 Saline Tris-EDTA (STE) solution, and 
0.2ml 10% sodium docyl sulphate (SDS, from Sigma, St. Louis, USA) were then added 
to digest the protein. The conical tube was tied to the rotors of incubator to allow 
rotation, and the incubation process was carried in 55°C hybridization oven for 
ovemight. In the next day, equal volume of 4ml tris-saturated phenol/chloroform/isoamy 
alcohol at the ratio 25:24:1 (Sigma, St. Louis, USA) was added to the conical tube and 
mixed. The solution was kept in -20°C for ten minutes and then centrifuged at 4000rpm 
for 20 min. to separate the phenol and chloroform phases. Proteins were expected to be 
trapped by the heavier bottom phenol layer. The upper aqueous phase was carefully 
transferred to another new conical tube. Two volumes of 8ml absolute ethanol (Merck, 
Darmstadt, Germany) with 0.4 ml of 3M sodium acetate (^H5.3) were added to the 
solution. After inverting the tube several times to mix well the reagents, the tube was 
left in -70°C for overnight to precipitate out the DNA. Finally, the alcohol was removed 
after centrifuging at 4000rpm for 20 min. The DNA pellet was vacuum dried and 
washed with 5ml of 70% ethanol which followed by vacuum drying. Afterwards, 
appropriate volume (depends on the pellet size) of sterile distilled water was added to 
dissolve the DNA pellet. The DNA was transferred to an eppendorf tube and kept at -
20°C for storage. 
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II. Biopsy specimens 
The procedures were basically the same as that of DNA extraction from blood, 
except two times of phenol/chloroform extraction and an extra step ofRNAse digestion 
were included. After the first time of Proteinase K digestion, phenol/chloroform 
extraction, and DNA precipitation in absolute ethanol as described previously, the DNA 
was re-dissolved in appropriate amount ofpH7.4 Tris-EDTA (TE). Then the following 
additional procedures were included for DNA extraction from tissues. It was done by 
first adding 30jil RNAse (10 jtU/ml，from Sigma, St. Louis, U.S.A.) to the DNA that 
dissolved in TE. The solution was left at 37°C Hybridization oven for 2 hours. 
Afterwards, 33 ^1 Proteinase K and 140 |il 10% SDS were added to the DNA and kept in 
hybridization oven for one hour. The second time of extraction with tris-saturated 
phenol/chloroform/isoamy alcohol was then performed as described previously. DNA in 
the top aqueous phase was removed after centrifugation at 4000rpm for 20 min. Two 
volumes of absolute ethanol and 0.4 ml of 3M sodium acetate (pH5.3) were added to 
precipitate out the purified DNA. This was followed by washing with 70% ethanol and 
vacuum dried. DNA was finally re-dissolved in appropriate amount of sterile distilled 
water, which then transferred to an eppendorf tube and kept at -20°C. 
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I c. Microsatellite Polymorphism Analysis 
I. Primers 
Twelve microsatellite polymorphic markers of chromosome 11 were used to 
examine LOH at the following loci (Table 3.1). Eleven ofthem mapped to the long of 
chromosome 11 and the additional pair of primer D11S926 mapped to the short arm 
(James et al, 1994). The sequences of the primers and chromosomal localization were 
according to Genome Data Base (GDB), Johns Hopkins University. These polymorphic 
markers were purchased from Research Genetics, Inc. (Huntsville, AL). Table 3.1 
summarized the mapping regions and some general information ofthe primers. 
Table 3.11nformation ofprimers. 
Primer Mapped region Length ofPCR ^^^jjj|j^^jjj^^j~~~^^^»^^— 
product (base pairs) temperature Heterozygosity 
(degree) 
n ^ ^ H p I ^ i 3 5 ^ ^ 可〜 
miS913 l l q l3 221-227 55° 58 
腸 2 l lql3.3 161-177 55� 85 
D11S901 l lq l4 160-176 53� 82 
D11S873 llql4.3-21 176-294 55� 90 
D11S900 llq22-23 91-109 56� 78 
D11S2000 llq22-23 213 55� 87 
D11S528 llq23.3 73-91 55� 0 
D11S1328 llq23.3-24.2 151-165 55� 74 
D11S934 llq23.3-24 180-206 55� 84 
D11S912 llq25 101-123 55� 81 
D11S968 llq24.1-25 137-155 55� 81 
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il Polymerase Chain Reaction (PCR) 
5 '-end labeling 
In each reaction, 0.25 pmoles of left primer was first end labeled with [y-^^ 
P]ATP (Amersham Corp., Buckinghamshire, United Kingdom), 0.025 X polynucleotide 
reaction buffer (United States Biochemical, U.S.A.) and 0.025^1 T4 polynucleotide 
kinase £1:3 diluted in T4 polynucleotide kinase dilution buffer from United States 
Biochemical, U.S.A.). This labeling process was carried for around halfan hour at 3 7 � C 
in either water bath or thermal cycler (Perkin Elmer/Cetus, Norwalk, CT). To avoid 
pipetting errors caused by pipetting of small volumes ofreagents, reaction mixtures ofat 
least 20 samples was prepared at each time. 
Reaction mixtures 
PCR was performed in 5^1 reaction volume, l^il of50-100 ng of extracted DNA 
ofeither tumor or normal sample was first placed in a 0.5ml micro test tube. The reagent 
mixture contained the labeled left primer, 0.25 pmoles ofthe right primer, 62.5 juM each 
of dNTPs (dATP, dCTP, dGTP, dTTP from Perkin Elmer/Cetus, Norwalk, CT), 1.0 mM 
MgCl2 (Perkin Elmer/Cetus, Norwalk, CT), 10 X PCR buffer (Perkin Elmer/Cetus, 
Norwalk, CT) and 0.125 unit of AmpliTaq DNA polymerase (Perkin Elmer/Cetus, 
Norwalk, CT). AmpliTaq DNA polymerase was always added at last. After the final 
mixture of reagents was mixed well, 4 i^l of them was distributed to each ofthe micro 
test tubes. One drop of sterile mineral oil (Sigma, St. Louis, USA) was added at the top 
ofthe mixture to prevent evaporation during PCR. 
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PCR 
All ofthe PCR reactions were conducted in a DNA thermal cycler (Perkin Elmer 
/ Cetus, Norwalk, CT). One drop of oil was added to each of the holes to ensure good 
contact between the micro test tubes and the wall of the thermal cycler. The reactions 
were started by first heated at 94°C for 5 minutes. Usually, 30-35 amplification cycles 
were performed. Each cycle included denaturation at 94°C for 40 seconds (s), annealing 
at 53 -56�C for 30s, and extension at 72�C for 30s. The annealing temperature for each 
pair of primer was optimized individually to restrict the binding ofprimers only to the 
designed DNA template location and with minimal background. After the amplification 
cycles, another 4 minutes was allowed for extension，which followed by gradual 
decrease of temperature to 4°C for temporary storage of PCR products in the thermal 
cycler. The finished PCR products were mixed with 45 jul ofloading buffer and kept in 
4 °C refrigerator for storage. 
iiL Electrophoresis 
Gel-preparation 
Mixtures of 6% polyacrylamide : bis solution (29:1) (BioRad, Hercules 
California, USA), 7M urea (United States Biochemical, U.S.A.), 1 X Tris-buffered-
EDTA (TBE), and ddH2O were dissolved with the aid of a magnetic bar. When the urea 
was completely dissolved, the gel solution was filtered through Whatman#l filter paper 
(Springfield Mill, England). After removal of gas, 10% Ammonium persulfate (Sigma, 
St. Louis, USA) and Temed (Pharmacia Biotech, Uppsala, Sweden) were added. The 
solution was poured into the clean glass plates for polymerization to form gel. One of 
the glass plates was coated with a layer of Acrylease (Stratagene, California, USA) to 
give a smooth surface that gels would not stick to it. Gels were expected to stick to the 
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un-coated clean glass plate. Shark tooth combs were placed between glass plates to form 
wells for sample loading. 
Electrophoresis 
Gels were firstly heated up for half an hour in 1 X TBE before loading samples. 
The PCR products (with buffer) were firstly heated at 95°C for around 10 minutes to 
denature the products to single strand. The wells were careftilly washed to remove the 
urea that diffused out from the gel. Around 1 to 1.5 ^1 ofPCR products was loaded to 
each well. The samples were then resolved by vertical electrophoresis through 6% 
denaturing polyacrylamide gel containing 7M urea for about 1.5 to 2.5 hours, depending 
on the sizes of the PCR products. The two size-markers of the buffer helps to identify 
locations of PCR products. After electrophoresis, gels were transferred onto 3mm 
Whatman no.l filter papers (Springfield Mill, England) as supports and covered with 
Saran Wrap. They were then dried in vacuum gel-dryer (Bio-Rad, Hercules California, 
U.S.A.) for 2 hours at 80�C. Loading volumes ofPCR products in cases with different 
ratios of signal intensities in the tumor and blood samples were further adjusted and 
polyacrylamide gel electrophoresis was repeated to give same ratio of signal intensities 
for comparison. 
IV. Detection 
The dried blots were transferred to cassettes and exposed to Kodak X-OMAT AR 
film for 4 hours to 1 day at room temperature depending on the signal intensities 
detected on the blots. In cases of weak signals, cassettes were kept in -70°C for 1 to 3 
days. Allelic imbalances were inferred visually when there were visible differences in 
the ratio of allele radiographic signal intensities in the tumor samples and the 
corresponding blood samples. For ambiguous cases, ultrascan laser densitometer 
(Pharmacia LKB, Uppsala, Sweden) was employed to detect the intensity variances of 
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the bands in X-ray films. Cases without two distinct bands of signals were classified as 
non-informative. Retain ofheterozygosity was scored when the signal intensities ofthe 
bands of the normal and tumor DNA products appeared to be the same. Loss of 
heterozygosity were assigned when the allelic ratio differences of tumor and blood 
control bands were greater than 30%. 
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I d. Multiplex PCR analysis 
Multiplex PCR analyses of microsatellite polymorphism were conducted to 
determine whether the allelic imbalances found in tumor samples were due to allelic 
amplification or loss ofheterozygosity. The DNA samples were investigated for the loci 
located at or nearby the regions with reported amplifications. These included loci 
D11S913, WT-2, D11S901, D11S873，D11S900 and D11S2000 which mapped to 
region llql3.3-23. An additional pair of primer (either MPO on chromosome 17q or 
D14S81 on chromosome 14q) was included as an internal control. The control primer 
was chosen depending on the molecular weight of PCR products of the microsatellite 
primers used. Separate and distinct groups of bands of the PCR products of both the 
desired and control primers were required for comparisons. Hence, MPO was used as 
control primer for the multiplex PCR target primers with PCR products in the range of 
150 and 250 base pairs, and D14S81 was that of the primers with PCR products around 
100 base pairs. The following table showed the combination of primers of multiplex 
analysis. 
Table 3.2 Combination ofprimers in multiplex-PCR. 
Primers |D11S913 |腿 - 2 D11S901 D11S873 |D11S900 jDllS2000 
(basepairs) (221-227) (161-177) (160-176) (176-294) (91-109) (213) 
MPO MPO MPO MPO MPO M ^ 
(104-110) (104-110) (104-110) (104-110) (104-110) (104-110) 
D14S81 D14S81 
(175-209) (175-209) 
Multiplex PCR were performed similarly as the traditional PCR method. The 
only difference is that two pairs of primers were included. Hence during the 5'-end 
labeling, two left primers were included. And the later on PCR reaction mixtures 
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consisted of the two corresponding right primers. Other PCR analysis steps were same 
as described previously. 
After the electrophoresis and detection steps, the PCR products ofboth the tumor 
and normal DNA samples were serially diluted depending on the signal intensities ofthe 
control primers. It was then resolved by further electrophoresis. An optimal dilution 
was chosen when the signal intensities of the internal control marker in both tumor and 
normal samples were normalized to be identical. The allele intensities ofatarget marker 
in tumor DNA versus normal DNA were compared and scored as in the case of 
traditional PCR analysis. 
Multiplex PCR on loci D11S913，JNT-2, D11S901, D11S873，D11S900 and 
D11S2000 were also conducted on four NPC cell lines, three NPC xenografts, as well as 
two other cell lines. Selection of internal control primers were chosen as in the analysis 
of primary NPC tumors. Table 3.3 lists the information of the investigated NPC cell 
lines and xenografts. 
Table 3.3 Information of the investigated NPC cell lines, NPC xenografts and other cell lines. 
NPC cell ？ ^ Other cell EBV References 
lines xenografts lines 
CNE-1 + absence Zhang et al (1982) 
CNE-2 + absence Guetal(1983) 
HK-1 + absence Huang et al (1980) 
cell-666 + presence Hui et al (1997) 
服1915 + presence Huang et al, (1988) 
xeno-666 + presence Huang etal, (1988) 
HK2117 + presence Huang etal,(1988) 
^ a + absence Jones etal, (1971)~~ 
CG3 + absence ~~Mok etal, (1987)~~ 
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II. Cytogenetic Studies 
II a. Culture of cell-666 
Cell-666 was derived from the xenograft xeno-666 (Huang et al, 1988). This 
xenograft was established from a biopsy of a NPC patient which defined 
histopathologically to be undifferentiated type. In xeno-666, part of the xenograft was 
taken out for cell culture in passage 18. Monolayer cell growth was successful up to 
passage 45, in which majority of the cells were carcinoma cells with minimal mouse 
fibroblasts. The successfully formed cell-666 were grown in a 25 cm^ culture flask 
O^unclon, Denmark) and cultured with RPMI 1640 which supplemented with 1% Fetal 
Bovine Serum (Gibco BRL, Grand Island, U.S.A.), 1% L-glutamine (Gibco BRL, Grand 
Island, U.S.A. ) and 1% penicilin/streptomycin (Gibco BRL, Grand Island, U.S.A.). 
The flask was kept at 37° incubator which supplied with humidified atmosphere 
containing 5% C02. 
The culture medium was changed twice a week. Fibroblasts were occasionally 
found in the cell culture. They were removed either mechanically or by slight 
trypsinization (base on the fact that fibroblasts are more easily detached than epithelial 
cells during trypsinization). In the mechanical way, the tip of a glass pipette was sealed 
with vigorous flame to be round ball shaped. Then fibroblasts were removed by 
scratching the areas of the flask that were with these unwanted cells. The process of 
slight trypsinization is very similar to normal trypsinization steps except with only two 
drops ofO.05% trypsin added. It was required to check constantly under microscope and 
remove the suspension when the fibroblasts started to detach. The cells were further 
rinsed with 5ml medium to remove any detached fibroblasts. Finally, another 5ml of 
fresh medium was added back to the flask and cultured continuously. These cells were 
subjected to further passage when they grew to around 90% confluence. 
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/• Passage of cells 
This step was done by completely removed the cells by trypsinization. The cell 
solution was then transferred to 15ml conical tubes and spinning down by centrifuge at 
500rpm for 5 minutes. After removal of supernatant, the cells was re-suspended in 15 
ml fresh medium and distributed to three clean 25 cm^ culture flasks. 
Basically，cells were maintaining to grow in 25 cm^ culture flasks with the 
medium RPMI 1640 which supplemented with 1% L-glutamine, 1% fetal bovine serum 
and 1% penicilin/streptomycin. The medium was changed twice a week and cells were 
subjected to further consecutive passage whenever they reach 90% confluence. 
//• Trypsinization 
The trypsinization procedure involved removal of old medium that followed by 
washing with 1 X PBS ^)hosphate buffer saline). Then treated with 0.05% trypsin 
(Gibco BRL, Grand Island, U.S.A. ) and followed by checking under phase-contrast 
microscope O^ikon, from Tokyo, Japan) for about 5-10 minutes. When the cells start to 
round up and with sign of detachment, 7ml of fresh medium was added to neutralize the 
trypsin solution. Several times of pipetting up and down was performed to help to 
remove the cells. After transferring the cells to 15ml conical tube (Falcon, Franklin 
lakes, U.S.A.) and spinning down by centrifuging at 500rpm for 5 minutes, the 
supernatant was discarded. The cell pellet was re-suspended in 5ml fresh medium and 
transferred to 25 cm^ culture flasks (Nfundon, Denmark) to grow. 
Upon passages #16 and #22, the cells were taken for cytogenetic analysis 
according to the traditional method. 
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II b. Cytogenetic Analysis 
L Harvesting 
Cells growing in 25 cm^ culture flasks were changed with another 5ml fresh 
medium the day before harvesting. Flasks with around 80% confluence were chosen for 
analysis. The harvesting procedures included blocking cells in the metaphase stage by 
adding 15 i^l of O.l^ig/ml colcemid (Gibco BRL, Grand Island, U.S.A.). After leaving 
the flask in 37�incubator for one hour, the cells were removed by trypsinization method 
and transferred to glass tubes. The cells were spinned down at 500rpm for 5 min. and 
the supernatant medium was removed. The cell pellet was dispersed with slight 
vortexing. 
iL Hypotonic treatment 
Hypotonic treatment was performed to swell up the cells by adding 8ml of0.05M 
KC1 solution (Sigma, St. Louis, U.S.A.) to the cells drop by drop, and with slight 
vortexing. The cell solution was left at room temperature for 18 minutes. 
iii. Fixation 
Before removal of KC1 solution, 0.25ml of fresh-made fixative [absolute 
methanol (Merck, Darmstadt, Germany) and glacial acetic acid (Merck, Darmstadt, 
Germany) in the ratio of3:l] was added to the cells for pre-fix. After spinning down the 
cells (centrifuging at 1800rpm for 10 minutes ), the supernatant was removed. Cell 
pellet was dispersed by slight vortexing. 5ml of fixative were added drop by drop to the 
cells, which followed by fixation at room temperature for 35 min. to two hours. 
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iv. Washing 
After spinning down the cells with 1800rpm for 10 min., the fixative solution 
was removed. The cells were dispersed and further washed with another 5ml fixative 
until the cell solution was clean. Usually, the washing step was repeated twice. Finally， 
the cells were suspended in appropriate amount offixative. (The cell solution can also be 
re-suspended in 10ml fixative and stored at 4°C for later use.) 
V. Incubation 
The cell solution was spread on clean slides. The slides were then pass through 
the steam of a beaker of hot water, and put in wooden box for overnight incubation at 
60�C oven. 
VI. Banding 
Dried slides were banded with standard trypsin-Giemsa banding technique 
(Seagbright et al., 1991) in the following day. Baked slides was first trypsinized in ajar 
of trypsin solution (0.05% trypsin in pH7.4 PBS) for 5 min., and stained with Wright 
stain solution (H.D. Supplies, UK) for around 10 min. Afterwards, slides were rinsed in 
pH6.8 PBS and followed by distilled water. The optimum concentration oftrypsin and 
staining time were chosen when they gave chromosomes with clear banding. 
vii. Analysis 
The karyotypes were analyzed under microscope according to the International 
System for Human Cytogenetic Nomenclature (ISCN, 1995). Representative metaphases 
were chosen when there were minimal overlapping of chromosomes and the banding of 
the chromosomes were sharp enough for analysis. 
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II c. Fluorescence in-situ hybridization (FISH) 
i. Preparation of slides 
The fixed cell suspension that stored at 4°C was used for FISH studies. The 
original fixative was spinned down and removed. 5ml of freshly prepared fixative was 
used for washing. The cells were re-suspended in appropriate amount of fixative and 
spread on clean slides as described previously. The procedures ofFISH were performed 
as recommended in the manufacturer's protocols (ONCOR). 
ii. Denaturation 
The commercially available digoxigenin-labelled total chromosome painting 
probes of chromosome 5, 11, 14 and 18 (digoxigenin labeled, ONCOR), as well as 
chromosome 6 and 12 (biotin labeled, Cytocell) were used. Denaturing procedures 
including treatment of probe and slides separately. Treatment ofthe probe was done by 
denaturing lO i^l of total chromosome painting probe at 70°C water bath for two minutes, 
which followed by incubation at 37�C for two hours. On the other hand, cell-666 slides 
were first dehydrated at serial concentrations (70%, 80%, 90%) of ethanol (Merck, 
Darmstadt, Germany) at room temperature with 2 minutes each. Slides were then 
denatured in 40ml 70% formamide/2 x SSC (pH 7.0) at 70�C for two minutes and 
dehydrated in a sequence (70%, 80%, 90%) of 40ml cold ethanol with 2 minutes each. 
iii. Hybridization 
Hybridization steps were carried out by applying the total chromosome painting 
probes (ONCOR) to the marked areas of slides that were with cells. The slides were 
covered with glass coverslip and sealed with rubber cement. They were put in a humid 
dark plastic box, which then kept in 37°C incubator for ovemight hybridization. 
58 
vi. Washing 
Post-hybridization wash was conducted by first carefully removed the coverslip 
and washed the slides with 40ml 1 x SSC (Sigma, Louis, U.S.A.) at 72°C for 5 minutes. 
The slides were then transferred to 40ml 1 x PBD wash solutions (ONCOR) at room 
temperature. Washing with 1 x PBD was repeated twice. 
V. Detection 
For chromosome 5: 
The signals were detected by adding 50 i^l Rhodamine-labeled anti-digoxigenin 
reagent to the slide (under dim light) and covered with plastic coverslip. Slides were left 
at 37°C incubator for 30 to 60 minutes. 
For chromosome 11，14 and 18: 
The signals were detected by adding 50 i^l FITC-labeled anti-digoxigenin reagent 
to the slide (under dim light) and covered with plastic coverslip which lefl at 37°C 
incubator for 30-60 minutes. 
For chromosomes 6 and 12: 
50^d of FITC-labeled Avidin reagent was added to the slides (under dim light) 
and covered with plastic coverslip. Slides were left at 37�C incubator for 30-60 minutes. 
Afterwards, the plastic coverslips were carefully removed, and slides were 
washed with 40ml 1 x PBD wash solutions (ONCOR) at room temperature. This 
washing step was repeated twice more. 
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vi. Amplification 
For chromosome 5: 
This was done by adding 50^1 ofRabbit Anti-sheep Antibody I (ONCOR) to the 
slide (under dim light) and covered with plastic coverslip which left at 37°C incubator 
for 5 minutes. Slides were then washed three times in 1 x PBD as previous washing 
steps. Then 50^1 ofRhodamin Anti-Rabbit Antibody II was added to the slide under dim 
light and covered with plastic cover slip and left at 37�C incubator for 5 minutes. 
Afterwards, slides were washed three times with 40ml 1 x PBD wash solutions 
(ONCOR). 
For chromosome 11, 14 and 18: 
50^d ofRabbit Anti-sheep Antibody I (ONCOR) was added to the slide (under 
dim light) and covered with plastic coverslip which left at 37�C incubator for 5 minutes. 
Slides were then washed three times in 1 x PBD as in previous washing steps. After 
that, 50^il of FITC Anti-Rabbit Antibody II was added to the slide under dim light and 
covered with plastic cover slip which then left at 37°C incubator for 5 minutes. 
Afterwards, slides were washed three times with 40ml 1 x PBD wash solutions 
(ONCOR). 
For chromosomes 6 and 12: 
5 0 - of Anti-Avidin Antibody (ONCOR) was applied to the slide (under dim 
light) and covered with plastic coverslip which left at 37°C incubator for 5 minutes. 
Slides were then washed three times in 1 x PBD as in previous washing steps. After 
that, 50 i^l of FITC-labeled Avidin was added to the slide under dim light and covered 
with plastic cover slip which then left at 37�C incubator for 5 minutes. Afterwards, 
slides were washed three times with 40ml 1 x PBD wash solutions (ONCOR). 
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vii. Counterstain 
Chromosomes 5, 6 and 12: 
10|il of O.l^ig/ml of DAPI in an antifade solution (ONCOR) was added to the 
slide for counterstain (under dim slight). It was covered with 18 X 40 mm^ glass 
coverslip. After leaving in room temperature for 30 to 60 minutes, slides were taken for 
analysis by checking signals under the epi-fluorescence microscope O^ikon, Tokyo, 
Japan). 
Chromosome 11，14 and 18: 
lO^d of 0.3^g/ml of propidium iodide in an antifade solution (ONCOR) was 
added to the slide and covered with 18 X 40 mm^ glass coverslip (under dim slight) for 
counterstain. After leaving in room temperature for 30 to 60 minutes, slides were taken 
for analysis by checking signals under the epi-fluorescence microscope (Nikon, Tokyo, 
Japan). 
viii. Analysis 
Metaphase were searched under low power of 10 X 10 and analyzed in higher 
power of 10 X 40. Photos of the representative metaphase spreads were taken for 
records. The high exposure film (Kodad EktarlOOO) was used. 
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II d. FISH analysis of other NPC cell lines 
Besides cell-666, FISH analysis on other NPC cell lines including CNE-1, CNE-
2, and HK-1 were performed. After retrieval of these cell lines from liquid nitrogen 
tank, they were allowed to grow in 25cm^ flasks. After two or three passages, 80% 
confluence cells were taken for harvesting as described previously. FISH analysis was 
performed similarly as in cell-666 with total chromosome probes of chromosome 11, 
which detected by FITC-labeled-anti-digoxigenin and counterstained with propidium 
iodide. 
Retrieval ofcell lines from liquid nitrogen stock 
Vials containing the cells were taken out and thawed at 37°C water-bath. It was 
then put in 10ml fresh medium and allowed to centrifuge at 500rpm for 5min. After 
removal of supernatant, the cells were re-suspended in 5ml medium and kept in 25ml 
culture flask. The medium contained RPMI 1640 as base medium and supplemented 
with 10% fetal bovine serum, 1% L-glutamine and 1% penicilin>/streptomycin. Normally, 
the medium was removed one day later and another 5ml offresh medium was put back 
to each flask for continuous growth of cells. Culture medium was changed twice a week 
and cells were subject to further passage when reached 90% confluence, as in cell-666. 




I: study of loss of heterozygosity on chromosome 11 
I a. LOH analysis 
DNAs of fifty-one undifferentiated primary nasopharyngeal carcinoma and their 
corresponding blood samples were assessed for LOH at chromosome 11. Eleven 
microsatellite polymorphic markers mapping to the long arm and one to the short arm of 
chromosome 11 were included. The results ofthe LOH analysis on the fifty-one tumor 
samples are shown in Figure 4.1 and briefly described in the following paragraphs. 
Twenty nine out of the fifty one cases (56.7%) showed allelic imbalances on at 
least one of the investigated loci at the long arm of chromosome 11. Please refer to 
cases marked with ‘‘ * ” in Figure 4.1. Figure 4.2 - Figure 4.4 illustrated the 
representative LOH pictures of each of the locus that mapped to chromosome 1 lq. In 
every locus, two representative cases showing LOH were illustrated. 
PCR analysis of another locus (D11S926) at the short arm of chromosome 11 
was also performed to investigate whether the region ofloss is only restricted to the long 
arm. Among the 36 informative cases, only seven cases (13.5%) had allelic imbalances 
at loci D11S926, as referred to Figure 4.1. These are cases 23, 24, 32, 36, 38, 40 and 41. 
Five of them (Case 23, 24，36, 40 and 41) had LOH on both p and q arms, and the other 
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Figure 4.1 Results of LOH analysis (Total # of cases = 51) 
Specimen Primers D11S926 D11S913 INT-2 D11S901 D11S873 D11S900 D11S2000 D11S528 D11S1328 D11S934 D11S912 D11S968 
NO. Location 11p15.4 11q13 11q13.3 11q14 11q14.3-21 11q22-23 11q22-23 11q23.3 11q23.3-24.2 11q23.3-24 11q25 11q24.1-25 
1 NP3-2 R R _ _ R R m R R R R Nl R R 
* 2 NP9-1 R Nl R Z L [ Nl “ L " T L N\ L 
* 3 NP13-1 R m R R R 一 R N*i Nl — L ^ \ L _ L 
4 NP 15-1 R R R ^ R R M R R R R R 
* 5 NP17-1 R M R Nl R R L R ~ R N^ R R 
* 6 NP18-1 R L L W W L \^ L L Nl L N\ 
* 1 NP20-1 R ^ L L L ^ R Nl L L ^ L 一 Nl 
Q NP21-1 R M R J^  J^  R Nl R— R Nl R R 
* 9 NP31-1 R W R R n\ R - L 1 l ' Nl R Nl 
10 NPC1T ^ R R m R M R R 一 Nl R R Nl 
11 NPC2T N| W R W R R R— R "^R R R — Nl 
12 NPC3T 1^  R R R M R R R — R R R Nl 
*13 NPC9T R m R m Nl ‘ ； , L ^ M Nl Nl R ~~N\ 
” 4 NPC11T R W R R M R R — R ~ N*I L — L 
15 NPC 14T R M M R R R R ND 一 R R Nl R 
*16 NPC16T J^  N| W R R Nl — R R R L Nl L 
* 1 7 NPC22T ^ N| R M R Nl 一 L Nl Nl ~ R R Nl 
*18 NPC23T R N^  1^  _R R R L _ R ~ N*i R ~ " Nl 
19 NPC24T R m 1^ R R R R R R Nl “ R Hl 
2 0 NPC 25T R M R R R R _R Nl R R “ R R 
2 1 NPC 26T R N| M R R M R R Nl R R 1^ 
* 2 2 NPC29T m ^ M Nl 國 Nl ~ N I _ R — R R R 
* 2 3 NPC 30T L R R M W R L M Nl L L L 
* 2 4 NPC 31T L N|_ ^ M M L L L L L L R 
2 5 NPC 32T R R R W R R R ^ R ^ R R 
* 2 6 NPC 34T m m R R R R R R Nl Nl L ^ 
* 2 7 NPC 37T R R Nl L L L L M L L L R 
Z Z i i _ N g ^ I ~ ^ N i ^ ~ " ^ ¾ ^ [ ^ [ _ ^ ; i I ^ I Z i ; Z 3 
* 2 9 NPC 39 T R M R R R R R R M L Nl U\ 
* 3 0 NPC 40 T R ^ R M L L L ^ ^ N| 1 ^ 
31 NPC 42T m M R ^ R R R R ^ ^ R U\ 
3 2 NPC 46T L R R R R R R M R R R R 
* 3 3 NPC 47T R ^ M 1^ M R L M R R R p 
^ NPC 48T R M R M W R M M M | ^ Nl Nl 
* 3 5 NPC 49T ^ NM R L M R W R R R R R 
* 3 6 NPC 51T L 1^ ______L L L L L M L L L [ 
37 NPC 52 T R M R m R R R Nn J^  Nl R R 
38 NPC 53T L 1^  N| 2il R R R R R R R Nl 
* 39 NPC 55T m ^ R M L W M L M L Nl i 
* 4 0 NPC 56T L R R J^ L L L L L L L R 
* 41 NPC 57T L INSTAB R J^  R R R ___^  L R ^ R R 
* 42 NPC 59T R R R L Nl M R R M R R R 
4 3 NPC61T 1^ M M R R N^ ^ 1^ R r^ R R 
4 4 NPC 63T ^ m M R R M ^ m ^ Nl Nl R 
* 4 5 CN 4T ^ L R L L L |^ M ND ' L Nl Nl 
* 4 6 CN 8T R L L [ ^ M L L W ^ ^ L Nl 
4 7 CN 9T J^ f ^ R R N] R |^ R R R Nl Nl 
* 4 8 CN 15T W R L M M R ^ [ ^ hm 1^ R R 
4 9 CN 16T R M R R R R [；^  R R R R R 
5 0 CN 20T R M R W R R R M R ^ R R 
5 1 CN 21T R R M W [；£ 1^ R ^ ^ R R R 

















































































































































































































































































































































































































































































































































































two cases (Case 32 & 38) had LOH on p-arm only. Figure 4.5 demonstrated two 
representative cases which were with LOH at this particular locus. Moreover, one out of 
the fifty one cases (case 41) showed instability in the locus D11S913, as illustrated in 
Figure 4.6. 
In addition, three cases (cases 6, 36, and 46) showed allelic losses on all the 
informative loci of 1 lq (Figure 4.1). Case 36 demonstrated allelic loss on both the short 
arm locus and all informative loci of the long arm. Hence, chromosome 11 of Case 36 
is suspected to be completely lost. Figures 4.7a & 4.7b illustrated the LOH pattern of 
this case. 
Table 4.1 showed the frequencies ofLOH ofall the studied tumors in the twelve 
chromosome 11 polymorphic loci. The highest frequencies ofLOH were found at region 
1 lq22-24, with 38.2% at D11S2000 and 39.3% at D11S934. 
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D11S926 D11S926 
Case (23) T N Case (24) T N 
- • • 一 “ 
Figure 4.5 Representative LOH analysis results in locus D11 S926. 
T = tumors, N = normals, arrows indicate loss ofheterozygosity. 
D11S913 
Case (41) T N 
• • • 
Figure 4.6 The instability case 41 in locus D11S913. T = tumors, 




























































































































































































































































































































































































































































































































































































































































I b. Regions with LOH 
I. First deletion region 
The first common region of loss was defined by the 8 cases (Cases 2, 7, 13, 30, 
35, 40, 42, 48), as illustrated in Figure 4.8. The region ofallelic loss on Case 2 included 
the loci D11S901，D11S873, and D11S900, where Cases 35 and 42 showed LOH on the 
locus D11S901 (Figure 4.8). All of these three cases retained heterozygosity at INT-2, 
which then defined the proximal margin of the region of loss. Case 7 showed LOH at 
n^T-2, D11S901 and D11S873 but retained heterozygosity at the locus D11S900 (Figure 
4.8). Moreover, cases 35 and 48 also showed retention at of locus D11S900. This 
suggested that D11S900 is the distal margin of the deletion region. As a result, this 
deletion region is located at chromosome llql3.3-q22 and lied between INT-2 
(llql3.3) and D11S900 (1 lq22-23) which included the deletion region at loci D11S901 
and D11S873, as shown in Figure 4.9. Nine out of the twenty-nine allelic imbalance 
cases (31.0%) demonstrated loss at either one or both of the two loci D11S901 and 
D11S873. LOH frequencies at these two loci were 28.0% for D11S901 and 20.6% for 
D11S873 respectively. 
iL Second deletion region 
The other distinct region of deletion was located at the telomeric part ofthe long 
arm of chromosome 11. Both cases 5 and 18 showed LOH at the locus D11S2000 
(1 lq22-23) but retained heterozygosity at D11S528 (1 lq23.3). On the other hand, case 
41 showed retain of heterozygosity at D11S2000 and LOH at locus D11S528. Hence, 
this region ofloss is located between D11S2000 and D11S528 at 1 lq22-23.3 (illustrated 
in Figure 4.8 & Figure 4.10). Nineteen of the twenty-nine allelic imbalance cases 
(65.5%) showed loss at one or both of the loci D11S2000 and D11S528. LOH 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































Furthermore, cases 14 showed LOH at D11S912 and D11S968. Cases 26 and 29 
illustrated deletions on the informative loci of D11S912 and D11S934 respectively. 
These cases indicated that another possible deletion region may start from D11S1328. 
However, case 16 showed retain of heterozygosity in D11S1328 and LOH on locus 
D11S934, which suggested the upper margin of deletion to be D11S1328. This 
suspected deletion region had the upper boundary at locus D11S1328 and included the 
loci D11S934, D11S912 and D11S968. Figure 4.11 demonstrated the LOH pattern of 










































































































































I c. Multiplex PCR analysis 
I. Analysis on Fifty-one NPC tumors 
Multiplex PCRs with the internal control primers MPO or D14S81 were 
performed at loci D11S913, ESfT-2, D11S901, D11S873, D11S900 and D11S2000 to 
determine the regions of amplification. Cases illustrating allelic imbalances in any one 
of these six loci were investigated. The results were illustrated in Figure 4.12. Only 
three of the allelic imbalance cases (case 22 at D11S873, case 28 at both ES[T-2 and 
D11S873) were found to be amplified instead of loss of heterozygosity. The rest ofthe 
allelic imbalances were confirmed to be LOH. In case 22, amplification was shown at 
locus D11S873, while LOH was found at D11S2000 (Figures 4.12 & 4.13a). Case 28 
demonstrated amplification at ESfT-2 and D11S873, but LOH on the locus D11S900, as 
shown in Figures 4.12 & Figure 4.13b. 
iL NPC cell lines，NPC xenografts and other cell lines 
Similar to the study ofNPC tumors, the multiplex PCRs were conducted with the 
internal control primers MPO or D14S81. Loci D11S913, JNT-2, D11S901, D11S873, 
D11S900 and D11S2000 were investigated. Among these six loci, all of the nine studied 
samples were found to have signals. Figures 4.14 a & b demonstrated the representative 
results. Figure 4.14a was the multiplex analysis result at locus INT-2. Multiple signals 
were found on all of the investigated NPC cell lines (CNE-1, CNE-2, Cell-666, HK-1), 
NPC xenografts (Xeno-666, HK1915, HK2117) and two other cell lines (Hela, CC3). 
Figure 4.14b illustrated the result of locus D11S2000. Similar to that of JNT-2, signals 
were detected in all of the nine samples. 
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Figure 4.12 Results of multiplex-PCR analysis 
Specimen Primers D11S913 INT-2 D11S901 D11S873 D11S900 D11S2000 
NO. Location 11q13 11q13.3 11q14 11q14.3-21 11q22-23 11q22-23 
2 NP 9-1 N| R ‘ , : : \ , ' ^ : ： ' 1 ' , / , ;J> 1^ 
5 NP 17-1 M R M R R L 
6 NP 18-1 L L ^ ^ L 1^ 
7 NP 20-1 W L L L R ^ 
9 NP31-1 1^ R R M R L 
1 3 NPC9T M R W M L M 
1 7 NPC22T ^ R W R M L 
1 8 NPC23T M ^ R R R L 
2 2 NPC29T M M N i g ’ , . .A 1^ L 
2 3 NPC30T R R M M R L 
24 NPC31T M W 1^  M Nl L 
2 7 NPC37T R j ^ L L L L 
2 8 NPC38T Nl M ^ S Nl ^ , . . , , , A L Nl 
3 0 NPC 40 T ^ R M L L L 
3 3 NPC47T W J^ J^ M R L 
3 5 NPC49T ^ R L W R Nl 
3 6 NPC51T W L L L L L 
4 0 NPC56T R R M L L L 
42 NPC 59T R R L ^ Nl R 
4 5 CN 4T L R L L L Nl 
4 6 CN 8T L L 1^ W L L 
4 s | CN 1 5 l | R! L J^ w R Nl 
L= loss of heterozygosity, R=retain of heterozygosity, 
NI=non-informative, A=amplification. 
T N T N 
D11S873 ^ ^ K ' D11S2000 fl|B| 
(A) • — „ (L) + ^ H 
^^^^^^^1 
彳 I 
• 塵 ^m 
^ ^ ^ 1 
Figure 4.13a Illustration of multiplex-PCR results in case 22. 
T N T N T N 
INT-2 M W M D11S873 D14S81 ; 





J D11S900 — > -
' | ^ ^ ^ (L) 
_ i ^ W i 血 _ 
~ ~ MPO 響 _ L——— 
Figure 4.13b Illustration of multiplex- PCR results ofcase # 28. L=LOH 
(indicated by arrow), R = retain ofheterozygosity. A= amplification 
(indicated by arrow head). T = tumors, N = normals. 
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II: Cytogenetic Study 
II a. Cytogenetic analysis of cell-666 
L At passage #16 
Figures 4.15 & 4.16 illustrated the metaphase spread and karyotype of cell-666 
respectively. It was found that the number of chromosomes of the 110 analyzed 
metaphase spreads were in the range of 40 to 46. 95% (104 out of 110) ofthem had the 
modal number of 45. The modal number of this cell line was sub-diploid (hypo-diploid). 
Followings were the identified numerical abnormalities: 
1. trisomy 9 
2. monosomy 14 
3. monosomy 18 
4. monosomy 21 
Several chromosomes with structural aberrations were identified. On the other 
hand, two markers were found to be consistently present in the analyzed metaphases. 
The origin of these two markers were unable to be identified. There were occasional 
appearance ofring chromosomes (6 in 110). The abnormal chromosomes were listed in 
the following and demonstrated in Figure 4.17: 
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The longest identified submetacentric chromosome was a derivative chromosome 
5. It was found to be a complex combination of chromosome 5 with several 
translocations involved and suggested to be: 
der(5)(5pter^5q31 ::5ql3^5q31 ::5pl2^5pter), as shown in Figure 4.17. The first 
break point was located at chromosome 5q31. An additional segment of 5ql3~>5q31 
was added to this break point. This was followed with the attachment of fragment 
5pl2^5pter to the 5q31 end of the segment of5ql3—5q31. 
There were two different abnormal chromosome 6, with 60 out of 110 spreads in 
one morphology and 50 of the other. The majority of abnormal chromosome 6 in this 
passage was found to be the der(7;6)Q)10;ql0) of figure 4.18a. As demonstrated in 
Figure 17，the abnormal chromosome 7 [add(7)(p22)] had an extra band added to the p-
terminal. One of the chromosome 11 [del(ll)(ql3)] consisted of deletion started form 
the q-arm at band 13. The abnormal chromosome 12 was found to be add(12)(^13) 
which with an addition dark band in p-terminal. One of the chromosome X [del(X)(q24)] 
had deletion at the telomeric region of q-arm. 
iL Passage # 22 
The structural and numerical anomalies of passage no.22 was similar to that of 
passage no.l6. Figures 4.19 & 4.20 were the representative metaphase spread and 
corresponding karyotype of cell-666 at passage #22. The chromosomal number of this 
passage ranged from 39 to 46，with 71.3% of the spreads (57 out of 80) have 45 
chromosomes. There was consistent appearance of the two marker chromosomes 
described in the previous passage (Figure 4.20). However, the majority of abnormal 
chromosome 6 appeared in the form shown in Figure 4.18b. Percentages of appearance 
of ring chromosomes also increased from 5.5% (6 out of 110) to 31.3% (25 out of 80). 
Figure 4.18c demonstrated the different sizes of the unidentified ring chromosomes, with 




chromosome 6 der(6)(7;6)(pl0;ql0) chromosome 6 der(6)(7;6)(pl0;ql0) 
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I. appeared more IL appeared more 
frequently in passage # 16 frequently in passage # 22 
c. 
0 a 
Figure 4.18. a & b: Comparison of the two derivative chromosome 6. 
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II b. Fluorescence in-situ Hybridization {FISH) 
I. Cell-666 
Using total chromosome 5 probe 
Evaluation of chromosome 5 FISH signals was conducted on metaphases. Three 
chromosome 5 specific FISH signals were identified in the 30 detailed analyzed 
metaphase spreads. In metaphases, the longest submetacentric chromosome was stained 
with the red Rhodamine color. There was another smaller chromosome found to have 
the Rhodamine color. Besides, one of the chromosomes was identified to have a small 
red fragment at the telomere of its q-arm. Figure 4.21 was the result of the chromosome 
5 FISH analysis. 
Using total chromosome 6 painting probe 
In the analysis of chromosome 6，two chromosome 6 specific FISH signals were 
identified in the 30 analyzed metaphases. The signals were in FITC color. The longer 
signal was on a chromosome (with the size of a normal chromosome 6) that painted 
completely with FITC color. Another FITC colored fragment was found on the long arm 
of another chromosome which had a similar size as the previously described one. Figure 




























































































Using total chromosome 11 painting probe 
Evaluation of chromosome 11 FISH signals was conducted on metaphases. One 
long and one short FITC signals were seen in all of the 30 detail analyzed metaphases. 
The longer FITC colored chromosome was referred to a submetacentric chromosome 
with the size of normal chromosome 11. The shorter FITC colored fragment appeared 
on another chromosome, as illustrated in Figure 4.23. 
Using total chromosome 12 probe 
In this analysis, evaluation of chromosome 12 FISH signals was conducted on 
metaphases. Two similar sized green FITC colored chromosome 12 specific FISH 
signals were observed in the 30 analyzed metaphases. One of the medium sized 
submetacentric chromosome was found to be completely painted with FITC color. The 
other FITC signal was found on another submetacentric chromosome. This particular 
chromosome had a small fragment of its p-arm not painted with FITC color, but the rest 






Using total chromosome 14 probe 
Evaluation of chromosome 14 FISH signals was conducted on metaphases. Two 
FITC colored chromosome 14 specific FISH signals were observed in the 30 analyzed 
metaphases. The longer signal was found on a chromosome with a size of normal 
chromosome 14. The other signal appeared as a small individual FITC colored 
fragment. Figure 4.25a illustrated the result of the chromosome 14 FISH analysis. In 
some metaphase spreads, the smaller signal occasionally presented on the centromeric 
part of a medium sized chromosome (data not shown). 
Using total chromosome 18 probe 
Three FITC colored chromosome 18 specific FISH signals were observed in the 
30 analyzed metaphases. The biggest signal was found on a chromosome which 
completely painted with FITC color. This chromosome has a size of normal 
chromosome 18. Another FITC signal was found on the centromeric part of a medium 
sized chromosome. Finally, the smallest signal was identified in the telomeric part of a 





iL Analysis of other NPC cell lines with chromosome 11 painting probe 
CNE-1 
Five FITC signals were found in the metaphase spreads. Four of them belonged 
to four separate but same sized chromosomes, with the size of normal chromosome 11. 
The other small FITC fragment were attached to one of the telomeric end of another 
small size chromosome, as shown in Figure 4.26a. 
CNE-2 
In this cell line, four FITC colored chromosome 11 specific FISH signals were 
observed in the metaphase spreads. Three of them belonged to three chromosomes that 
with the size of normal chromosome 11. The other small FITC fragment were identified 
at one of the telomeric end of another similar sized chromosome, as shown in Figure 
4.26b. 
HK-1 (915) 
The results of HK-1 analysis is more complicated than the others. In the 
analyzed metaphase spreads, seven individual chromosomes were identified to be 
stained with FITC colors. Firstly, the central part of a long chromosome was stained 
with FITC color. Another two signals were detected on most part of two medium sized 
chromosomes. The telomeric regions of these two chromosomes were not painted with 
FITC colors. There was another chromosome which with a small area of both its p-ter 
and q-ter painted with FITC color. The rest of the three signals were found at the 
telomeric part of three separate chromosomes, as demonstrated in Figure 4.27. 
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Figure 4.27 FISH analysis result ofchromosome 11 in HK-1. 
CHAPTER 5 
DISCUSSIOM 
I. LOH of Chromosome 11 Studies 
We have investigated the LOH pattem along the long arm of chromosome 11 in 
fifty one primary NPC tumors with eleven microsatellite polymorphic markers. LOH 
was detected in 56.7% of the fifty-one NPC tumor samples. Two distinct regions of 
deletion at llql3.3-22 and llq22-23.3 were found. The loci m j - 2 and D11S900 
defined the first deletion region. The second one lied between loci D11S2000 and 
D11S528. Multiple independent LOH regions on chromosome 11 had been previously 
reported in breast cancer, ovarian cancer and adenocarcinoma of lung 0S[egrini et al, 
1995, Gabra et al, 1996, and Rasio et al, 1995). Our results demonstrated that 
nasopharyngeal carcinomas shared with these solid tumors of similar multiple genetic 
alterations on chromosome 1 lq. 
The first region of loss was defined by JNT-2 and D11S900 at llql3.3-22, 
including the loci D11S901 and D11S873. This region ofloss is within the llql3-23.3 
deletion region identified in the carcinoma of bladder (Shaw et al, 1995). LOH on 
chromosomal 1 lql3 ( at the locus INT-2) was frequently reported in male breast cancer, 
in situ and invasive carcinoma of the female breast cancer and multiple endocrine 
neoplasia type-1 associated tumor (Sanz-Ortega et al, 1995, Zhuang et al, 1995 and 
Lubensky et al, 1996). Introduction of an intact copy of chromosome 11 caused a sharp 
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reduction in either cell growth or tumorigenicity in two melanoma cell lines, with the 
effect was enhanced in cells that received an isochromosome l l q (Robertson et al, 
1996). Furthermore, transfer of the normal chromosome region 1 lql3-q23 into a breast 
cancer cell line MCF-7 was shown to significantly decrease the tumorigenicity of that 
cancer cell line in nude mice OSfegrini et al, 1994). Hence, a putative tumor suppresser 
gene(s) may be located in this common deletion region. Presumably, this putative 
TSG(s) may play a role in the development of NPC as in other human cancers. 
k 
Previously, there was no LOH studies conducted to investigate this deletion region in 
detail. LOH study with more cases of primary NPCs can be performed to confirm the 
boundaries of the deletion region, as well as to investigate its correlation with NPC. As 
infiltration of stromal tissue can mask some allelic imbalances cases, application ofmore 
sensitive LOH detection methods (such as the use of microdissection to select areas with 
tumors) may also help us to obtain a more accurate percentage ofLOH in NPC tumours. 
Previous cytogenetic studies of undifferentiated NPC xenografts illustrated 
rearrangement of llql3-qter in a NPC xenograft (Huang et al, 1989). Cytogenetic 
analysis of the newly established EBV-associated NPC cells (cell-666) showed 
consistent loss of the long arm of chromosome 11 starting from around the 1 lql3 region 
to q-ter. These results demonstrated that chromosomal alterations ofthe l l q l3 - l l q ter 
appeared to be a common event in NPC cell line, NPC xenografts and primary NPC 
tumors. 
The proto-oncogenes INT-2/FGF3, HSTl/FGF4, BCL1, PYGM, PRADl/Cyclin 
D1, EMS1, and F0LR1 are located on the chromosomal region 1 lql3 (Karlseder et al, 
1994，Lese et al, 1995). These genes demonstrate amplification in many tumors such as 
breast, head and neck and ovarian cancers. (Foulkes et al, 1993, Lese et al, 1995, and 
Champeme et al, 1995). Amplification at chromosome l l q l 3 has been reported as one 
of the main genetic abnormalities in breast tumor (Champeme et al, 1995). Moreover, 
amplification of INT-2/FGF2 and Cyclin D1 in l l q l3 might play an important role in 
local relapse of breast cancer (Champeme et al, 1995). The gene of adult high-affinity 
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folate receptor was found to map to region 1 lql3.3-13.5 and amplified in ovarian cancer 
(Foulkes et al, 1993). Furthermore, l l q l 3 amplification was detected in 30%-50% of 
head and neck squamous cell carcinomas (Somers et al, 1990, Field et al, 1996). As a 
result, this l l q l 3 region was suggested to contain oncogene(s) involved in the 
development ofmany tumors. Of particular interest is Cyclin D1 which was suggested to 
be the target gene with the greatest prognostic significance (Field, 1996). D-type cyclins 
are found to be ftindamental to cell cycle regulation (Field, 1996). Cyclin D1 genes 
involve in the regulation of early cell division cycle events and play a role in neoplasia 
(Dickson et al, 1995). 
As amplification of chromosome l l q l3 seems to be important in the 
tumorigenesis of many solid tumors, we used multiplex PCR analysis to investigate the 
allelic imbalance cases of this particular region and its nearby regions. The pair of 
internal control primers allow us to compare signal intensities of the interested primers. 
We can then distinguish cases with increased signal intensities (amplification) and those 
with reduction of intensities (LOH) in the investigated loci. However, amplification of 
the 1 lql3 region appears to be a rare event in NPC. In our study, two ( Cases 22 and 28) 
out of the fifty one cases were identified to have amplification at locus D11S873 
(llql4.3-21). In one of these two cases (case 28), amplification was also detected in 
locus JNT-2 which located at llql3.3. Moreover, no obvious l l q l3 amplification was 
identified in karyotype of cell-666. More studies are required to further define the 
significance of chromosome l lq l3 amplification in NPC tumorigenesis. For example, 
amplification of l l q l3 in paraffin sections of primary NPC tumors can be fruther 
investigated using the technique of FISH with sequence specific probes for chromosome 
l l q l3 region. 
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The frequency of LOH in the long arm of chromosome 11 at 1 lq22-24 region is 
much higher than that of the 1 lql3-14 region in NPC. Among the eleven microsatellite 
polymorphic loci investigated in NPC tumors, the two loci D11S2000 and D11S934 at 
llq22-24 region showed the highest frequencies of LOH with 38.2% and 39.3% 
respectively. LOH on chromosomal region llq22-24 was also frequently detected in 
cervical cancers, breast, lung and ovarian (Hampton et al, 1994, Rasio et al, 1995, 
Negrini et al, 1995, Gabra et al, 1996). Study oflung adenocarcinoma identified 63% of 
LOH at llq22-24 (Rasio et al, 1995). In breast cancer, high frequency of LOH was 
detected in llq22-23 and llq23 (Carter et al, 1994, Winqvist et al, 1995). Analysis of 
cervical carcinoma reported 44% of the studied cases demonstrated clonal genetic 
alterations resulting in LOH (Hampton et al, 1994). 
In our study, another distinct deletion region was found at llq22-23.3, located 
between the loci D11S2000 and D11S528. This second region of loss was originally 
defined by the two loci D11S2000 and D11S934 and located at 1 lq22-24 in our previous 
report (Hui et al, 1996). Additional LOH studies on NPC primary tumors using two 
more llq23 polymorphic markers D11S528 and D11S1328 were conducted. Cases 5， 
18 and 41 (in Figure 4.8) further fine-mapped this deletion region to be defined by 
D11S2000 and D11S528. This region ofloss overlapped with the regions showing LOH 
reported in some other solid tumors. It overlapped with regions ofloss in cervical cancer, 
ovarian cancer, as well as part of the first and second deletion regions reported in lung 
adenocarcinoma (Hampton et al, 1994, Gabra et al, 1996 and Rasio et al,1995). In 
stomach adenocarcinoma, region ofLOH was identified at 1 lq22-23 (Baffa et al, 1996). 
The smallest region of shared LOH was found to be located between 1 lq22 and 1 lq23.3 
in sporadic human breast carcinoma (Hampton et al, 1994). 
Moreover, there are also several cases which demonstrated deletion in the 
telomeric region of chromosome 11. The cases 14, 26 and 29 showed LOH in the 
informative loci of D11S1328, D11S934, D11S912 and D11S968. But case 16 
demonstrated deletion beginning at D11S934. Another possible region of loss at 
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llq23.3-qter may have loss started from D11S934 to the telomere of chromosomell, 
with D11S1328 as its upper boundary. This deletion region overlapped with the second 
region ofloss in ovarian cancer (Gabra et al, 1996). LOH at this region is less frequently 
reported in other cancers. As this deletion region is defined by only one case, more cases 
are required to be investigated before more conclusive suggestions can be made. 
Analysis of microsatellite instability (or replication error repair) in tumor 
specimens are usually associated with defects in DNA repair genes. This technique has 
been used to assess genetic damages in the genome of sporadic cancers (Field, 1996). 
Head and neck squamous cell carcinoma is one of the cancers that illustrated 
microsatellite instability. In our study, only one case of microsatellite instability was 
identified. Case 41 illustrated microsatellite instability at the locus D11S913 (Figure 
4.6). Hence, potential mutation of genes on chromosome 11 involved in replication 
repair may not be a frequent event in the pathogenesis ofNPC. 
LOH ofthe long arm of chromosome 11 was frequently detected in primary NPC 
tumors. We further investigated the deletion pattem ofthree NPC xenografts, three NPC 
cell lines and two other cell lines. As the corresponding controls were not available, we 
could not detect LOH on these samples. Results demonstrated that signals were present 
in all ofthe samples in the investigated loci. Hence, there were no homozygous deletion 
of these samples among the loci D11S913，ESfT-2, D11S901, D11S873, D11S900 and 
D11S2000. 
Figure 5.1 compared the deletion pattem of chromosome 1 lq in NPC with that of 
bladder, cervical, ovarian, breast and lung cancers. Shared common deletion regions 
were summarized from the chromosome 1 lq deletion pattem. The most common shared 
deletion region lied between D11S2000 and D11S897. This is one ofthe two minimal 
deletion regions reported in breast cancer O^egrini et al, 1995). This particular region 
was included in the deletion regions of all the solid tumor types in Figure 5.1. In the 
upper part of this shared deletion region, loci D11S940 and D11S900 defined another 
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common deletion region at llq22. This deletion region shared by all of the described 
tumor types of Figure 5.1, except breast cancer. On the other hand, D11S897 and 
D11S490 defined the third common region of loss in NPC, bladder cancer, cervical 
carcinoma, ovarian cancer as well as lung adenocarcinoma. All of these three common 
deletion regions are overlapping with the regions showing frequent allelic loss (llq22-
24) in NPC. Multiple putative tumor suppresser genes which located at these areas are 
then suggested to be involved in the development ofNPC. 
The shared common region of deletion D11S2000-D11S897 identified in Figure 
5.1 was reported to be less than 10 Mb (Vanagaite et al, 1995). It was found to coincide 
with the minimal region that comprise the AT locus (^egrini et al 1995, Rasio et al, 
1995). As a result, the second common deletion region at 1 lq22-23 identified in NPC 
included the AT locus as well. Heterozygous state of AT carriers had been correlated to 
have increased risk of developing cancers of lung, pancreas, gallbladder and stomach 
(Gatti et al, 1991). Moreover, women with AT heterozygous were reported to have five 
fold increase of breast cancer (Swift et al, 1987). ATM gene is identified as the gene 
responsible for AT phenotype (Savitsky et al, 1995). 
The exact flinctions of the ATM gene products is still not well understood. The 
sequence of the ATM gene suggested that its gene products may participate in signal 
transduction, cellular response to DNA damage and cell cycle control (Savitsky et al, 
1995). Encoding a putative protein homology similar to phosphatidylinositol-3 (PI-3) 
kinase, ATM gene product was suggested to be a member of human 'PI-3 kinase like, 
signal transduction family and involved in the transduction of signals associated with 
maintenance ofgenomic stability, cell viability and protection against ionizing radiation 
(Jorgensen and Shiloh, 1996). 
The DNA Damage Surveillance Network proposed that ATM protein activates 
several cellular functions along the signal transduction network (Meyn, 1995). Loss of 


























































































































































































































DNA damage, unable to prevent the triggering of programmed cell death, and cannot 
activate damage-inducible DNA repair (Meyn, 1995). Moreover, ATM gene is 
identified to be closely related with the p53 gene. Wild-type ATM gene may interact 
with p53 protein to inhibit the p53 mediated activation of apoptosis. Alternatively, 
ATM protein may indirectly counteract p53 mediated apoptosis by inhibiting a step in 
apoptosis that is downstream of p53 (Meyn, 1995). No hot spot of mutation has been 
identified in previous studies of ATM gene (Igor et al, 1996). 
As in other cancers that illustrated LOH at 1 lq23 such as breast cancer and lung 
adenocarcinoma, ATM may be one of the candidate putative tumor suppresser genes on 
chromosome l l q which involved in the development ofNPC. However, the gene spans 
approximately 150 kb of genomic DNA and consists of 66 exons, we are expecting that 
the association of ATM gene and NPC can be investigated when there is more 
information of ATM gene reported. 
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II- Comparison with LOH studies of other chromosomes 
Like many other different types of solid tumors, the carcinogenesis of 
nasopharyngeal carcinoma (NPC) is suspected to be a multi-step process. Several 
chromosomal abnormalities have been reported in NPC. Early cytogenetic studies 
observed non-random deletion at chromosome 3p. Additional molecular genetic 
analysis had demonstrated high frequency of allelic loss in chromosome 3pl3-3pl4.3 
(Huang et al, 1991, Lo et al, 1994). In chromosome 9, high frequency of LOH were 
identified in 9p21-9p23 of primary NPC (Huang et al, 1994). Moreover, the 
chromosome llqter deletion was identified in our newly established long term cultured 
NPC cells cell-666. This deletion of l lq was confirmed by fluorescence in-situ 
hybridization. The highest frequency ofLOH were found at the long arm ofchromosome 
11 at llq22-24. 
To investigate the correlation of LOH results in chromosomes 3，9 and 11, a 
comparison in regions showing highest frequencies of LOH was made. This compared 
the 24 NPC cases which have been investigated in the molecular analysis of all of the 
three chromosomes. The results were shown in Figure 5.2 and Table 5.1. 
Table 5.1 Regions with highest frequencies of LOH in chromosomes 3, 9 and 11. 
Region of deletion % ofallelic loss 
3pl3-3pl4.3 66.7% (16 out ofthe 24 cases) 
9p21-9p23 58.3% (14 out ofthe 24 cases) 
llq22-llq24 50% (12 out ofthe 24 cases) 
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Figure 5.2. Results ofthe LOH analyses in 
Chromosomes 3，9，& 11 
Case# 3pl3-pl4.2 9p21-p23 llq22-q24 
(Lo et al., 1994) (Huang et al., 1994) 
I o o • 
• • • 
3 0 C D • 
4 0 0 0 
5 0 0 0 
• • • 
7 • 0 • 
8 0 0 0 
9 ^ 0 0 
10 o • • 
I I o o o 
12 CZ> 0 0 
13 C D o o 
14 CZ> • 0 
15 d：：> CZ> CZ> 
16 • 0 0 
17 0 • • 
18 CZ> 0 参 
19 d > o o 
20 • • • 
21 0 • d > 
22 • • • 
23 • • • 
24 0 C D • 
^ ^ ^ cases with deletion ^ ^ cases without deletion 
It was found that 20 out of the 24 cases (83.3%) demonstrated allelic loss on at 
least one of the chromosomes. Within this 20 cases, 9 of them (45.0%) were found to 
have loss on all ofthe three chromosomes. The percentages of deletion in chromosome 
3 and 9 are 66.7% (16 out of the 24 cases) and 58.3% (14 out of the 24 cases) 
respectively. Among these 24 cases, chromosome 11 studies showed that there were 12 
cases (50%) demonstrated deletion at this region. On the other hand, there were two 
cases (8.3%) had allelic loss only on chromosome 3, and one case (4.2%) in either 
chromosome 9 or 11. Hence, the possibility that one of these genetic alterations alone is 
more dominant in the carcinogenesis of this cancer seems unlikely. 
In conclusion, our study demonstrated two distinct common regions of LOH at 
the long arm of chromosome 11 at ql3.3-22 and q22-23.3 in primary nasopharyngeal 
carcinoma. This suggests the presence of multiple putative tumor suppresser genes on 
chromosome l lq. They may act together with other genetic alterations such as 
chromosomal deletions of 3p and 9p, as well as homozygous deletion of pl6 gene in a 
multistep process leading to the development of this cancer. 
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III. Cytogenetic Studies 
We have performed the cytogenetic analysis of a long term cultured EBV-
positive NPC cells. It is one of the rare existing NPC cell sources that still carries the 
EBV genome. Passages no. 16 and 22 of this cell-666 both demonstrated a modal 
number of 45 and with very similar structural chromosomal aberrations. The involved 
chromosomal anomalies have been consistently found in the continuing passages. 
Furthermore, some of these chromosomal alterations were similar to the previously 
reported cytogenetic analyses of other NPC cell lines or xenografts, as briefly discussed 
in the following paragraphs. Presence of these common chromosomal abnormalities in 
NPC cell lines will be helpful in understanding the pathogenesis ofthis cancer. 
Passages #16 and #22 of cell-666 have very similar karyotype. The marker 
chromosomes consistently appeared in the analyzed metaphase spreads of the two 
passages. Except in the later passage, the ring chromosomes appeared more frequently. 
There were different patterns of the ring chromosomes which seemed to be bigger in 
some metaphases but sometimes is smaller. The increased in frequency of the ring 
chromosomes is suggested to be induced by the in vitro cell culture system rather than 
genuine characteristic of this cell line. 
Karyotype of cell-666 differs from the cytogenetic analysis of most of the 
previously reported in vitro NPC cell lines (CNE-1, CNE-2, HK-1, TW039 and its 
sublines), both numerically and structurally. This may be due to the differences in the 
origin or passage time of the cell lines. Chromosomal number ofthese cell lines were all 
hyper-aneuploidy (Zhang et al, 1982，Zhang et al, 1983, Tien et al, 1990, Huang et al, 
1980). However, cell-666 has a near diploid modal number of 45 which is closer to the 
cytogenetic data ofthe other three near-diploid cell lines reported in 1993 by Bemheim 
et al. These three cell lines were derived from NPC xenografts growing in athymic nude 
mice (Bemheim et al, 1993). The common route of xenografting in athymic nude mice 
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which followed with cell line establishment of those by Bemheim et al and celll-666 
may share some common selective growth advantages in these four near-diploid lines. 
Furthermore, difference in the origin of tumors may affect the characteristics of these 
cell lines. Cell lines CNE-1 and HK-1 were established from well differentiated 
squamous NPCs (Zhang et al, 1982, Huang et al, 1980). But CNE-2 and cell-666 were 
established from poorly differentiated and undifferentiated NPCs respectively (Zhang et 
al, 1983). Poorly differentiated squamous NPCs and undifferentiated carcinomas 
account for more than 95% of the NPC tumors among the southern Chinese. 
Both CNE-2 and cell-666 were established from EBV positive NPC biopsies 
(Zhang et al, 1983, Huang et al, 1989). While CNE-2 gradually lost the EBV genome, 
cell-666 retains the EBV genome which is demonstrable by the consistent presence of 
EBERs. Moreover, cell-666 was analyzed in much earlier passage compared to other 
cell lines such as CNE-1 and CNE-2. This would decrease the possible chromosomal 
changes induced by in vitro system. Thus cell-666 provides a more accurate reflection 
ofthe cytogenetic details of the primary tumors. 
Even though no consistent common abnormal chromosomal aberrations being 
reported in NPC, there exist some similarities between the abnormal chromosomes 
identified in cell-666 and that of the other NPC cell-lines or xenografts. Firstly, the 
derivative chromosome 5, der(5)(5pter^5q31 ::5ql3^5q31 ::5pl2^5pter) of cell-666 
is the largest identified chromosome that was suspected to be a complex derivative of 
chromosome 5 which involved break points in the region 5q31. This identification was 
confirmed by FISH analysis using total chromosome 5 painting probe. The longer signal 
was painted on the longest chromosome and hence indicated that it was a derivative 
chromosome 5. A small size chromosome painted with another chromosome 5 specific 
signal showed that this is a partial fragment of chromosome 5. The smallest signal 
identified in part of a small size chromosome showed that part of chromosome 5 was 
involved in the translocation with another unknown chromosome. As a result, abnormal 
chromosome 5 rearrangements identified in cell-666 included deletion and translocation. 
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Similar giant marker chromosome 5 were identified in C17 and CNE-1 (Bemheim et al, 
1993，Zhang et al，1982). However, as there was no detail description of these marker 
chromosomes, we could not confirm whether all of these markers are identical. 
Consistent 5q+ abnormally was also reported in another study of NPC biopsies by 
Kristensen et al in 1991. Hence, the region 5q31 may be a common break point involved 
inNPC. 
An abnormal chromosome 6 showing translocation with an unknown 
chromosome had been reported in the cell line NPC-TW039 (Tien et al, 1990). We have 
also identified a similar chromosome 6 derivative der(7;6)(plO;qlO) in cell-666. FISH 
analysis revealed that one of the chromosome 6 was involved in translocation with an 
unknown chromosome. The q-arm of chromosome 6 fused with the p-arm of that 
unknown chromosome. Moreover, the additional band on the p-ter of the aberrant 
chromosome 7 was not able to be identified. No similar chromosomal aberrations for 
chromosome have been reported in previous NPC cytogenetic studies. 
The l l q l 3 deletion identified in the cytogenetic analysis of cell-666 was 
consistent to the LOH study results of primary NPC tumors (Hui et al, 1996). With the 
usage ofwhole chromosome 11 painting probe in FISH analysis, two signals have been 
identified. The longer signal was referred to a normal submetacentric chromosome 11 
and another shorter chromosome 11 which with its telomeric part of the q-arm deleted. 
This confirmed that the telomeric q-arm deletion of chromosome 11 is merely a 
chromosomal deletion but not involved in other rearrangements. However, FISH studies 
on other NPC cell lines (CNE-1, CNE-2 and HK-1) using chromosome 11 painting 
probe demonstrated different results. In these latter three cell lines, both extra copies of 
chromosome 11 and translocated chromosome 11 were identified. On the other hand, 
there was no individual chromosome 11 which showing deletion on q-arm as that ofcell-
666. Hence, the del(l l)(ql3) may be an unique feature ofcell-666. 
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An abnormal chromosome 12 [add(12)(pl3)] with an addition dark band in p-
terminal was found in cell-666. This was confirmed by FISH which showed that one of 
the chromosome 12 with one telomeric region not painted with chromosome 12 specific 
probe. Previous study ofNPC xenografts identified presence of 12ql3~>qter in three out 
o f the six markers (Huang et al, 1989). Deletion of 12p l l^p te r and involvement of 
12ql3">pter were reported in cytogenetic analysis of fresh NPC biopsies (Kristensen et 
al, 1991). This suggested a possible association of abnormal chromosome 12 with NPC. 
Monosomy 14 had also been reported in Ali bin Ali, C17 and C19 (Mitelman et 
al, 1983, Bemheim et al, 1993). FISH results demonstrated that, in addition to the 
normal chromosome 14，another chromosome 14 fragment was presented. In FISH 
analysis of chromosome 18, two small chromosome 18 fragments were discovered to be 
translocated with other unknown chromosomes. This indicated that the lost copy of 
chromosome 18 was not simply missing, but involved in other chromosomal 
rearrangements. Trisomy 9 had been identified in CNE-2, xeno-1 and xeno-2 (Zhang et 
al, 1983, Huang et al, 1989). Monosomy 21 was found in cell line Ali bin Ali (Mitelman 
et al, 1983). The deleted chromosome X [del(X)(q24)] was previously reported in NPC-
TW039 and its subline, as well as NPC biopsies (Tien et al, 1990, Kristensen et al, 
1991). However, the abnormal 3q+ marker chromosome and iso 8q that have been 
frequently reported in other NPC cell lines were absent in cell-666 (Zhang et al, 1983, 
Tien et al, 1990). 
Previous molecular studies have demonstrated frequent allelic loss on the short 
arm ofchromosome 3 and that of chromosome 9, as well as homozygous deletion ofthe 
P l 6 gene (Lo et al, 1994, Huang et al, 1994, Lo et al, 1995). Molecular genetic 
investigations reported that hypermethylation of the 5'CpG island of the pl6 gene was 
located at 9p (Lo et al, 1996). Deletion of chromosome 3p was found in a xenograft 
named xeno-1 (Huang et al, 1980) and cell line HK-1 (unpublished data). Cell line C19 
(Bemheim et al, 1993) was reported to consist of chromosome 9p deletion. However, 
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cell-666 did not show any obvious chromosomal deletions on either of these 
chromosomes. 
In summary, we have reported the structural and numerical chromosomal 
abnormalities of a newly established long term cultured NPC cell source cell-666. 
Having a near diploid modal number and with retention of EBV after continuous 
passages, cell-666 is potentially a good in-vitro system for further molecular 
investigations of nasopharyngeal cancer. It is also a better tool than the other 
established NPC cell lines for the study of the tumorigenesis of NPC. Conventional 
cytogenetic analysis gives a gross picture of structural and numerical chromosomal 
abnormalities. Application of FISH confirmed some of the suspected chromosomal 
abnormalities. FISH also revealed some other chromosomal aberrations such as 
deletions and translocations which are not observed in karyotypings. However, there are 
still some unknown chromosomal aberrations and markers which cannot be identified 
using only conventional cytogenetic techniques and FISH analysis. For example, the 
identity of the two marker chromosomes is still unknown. And we cannot identify the 
chromosome that involved in the translocation with the derivative chromosome 6. These 
unknowns are expected to be revealed with the help ofsome more advance techniques. 
The limitation ofperforming karyotype analysis on solid tumors can be overcome 
by using comparative genomic hybridization, multiplex-FISH (M-FISH) or spectral 
karyotyping (SKY). CGH is a molecular cytogenetic technique used for rapid detection 
ofchromosomal gains and losses in a genomic complement (Kallioniemi et al, 1993). It 
is based on a two-color fluorescence in situ hybridization of differentially labeled tumor 
and normal genomic DNA which competitively hybridize to normal human metaphase 
spreads. The tumor and normal DNAs are usually detected by green and red 
fluorescence colors respectively. Upon fluorescence microscopy, the ratio ofthe green 
and red fluorescence intensities can reflect any over-represent or under-represent of 
117 
tumor DNAs (Houldsworth and Chaganti，1994). On the other hand, M-FISH and SKY 
using a set of differently labeled chromosome libraries hybridized simultaneously to 
metaphases (Speicher et al, 1996, Schrock et al, 1996). The chromosomes were labeled 
with fluorophores by combinatorial strategies. This allows automate karyotype analysis 
for classification of each of the human chromosome. Hence, these techniques can be 
used to interpret complex chromosomal aberrations, as well as to identify marker 
chromosomes and chromosomal rearrangements. M-FISH and SKY allow classification 
of each chromosome but cannot illustrate the chromosomal regions. CGH shows the 
chromosomal region of deletion and amplifications but gives no information about 
balanced translocations. Karyotype analysis can identify the specific involved 
chromosomal regions. Hence, combination of all of these three techniques may be able 
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